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pC-momorcharin (x-MMC), a glycoprotein extracted
from the seed of Momordica charantia, was shown to be
effective in inducing abortion of mid-term pregnant mice
(i.e. on the 10th day of pregnancy) at a dose of
0.2mg/25g body weight. The aims of the present
investigation are to study the drug effect on the levels
of chorionic gonadotropin (CG), oxytocin-induced isolated
uterine contractility and histological changes of the
placenta following administration of D(-MMC in order to
elucidate the mechanisms of its action.
Gross morphological studies showed that a-MMC
caused fetal death and the average placental weight of
the treated mice was lower than that of the control.
Disorganisation of fetuses and placentae were prominent.
Histological observations showed that the drug seemed to
act on the placentae at the site of trophoblastic cells.
Then degeneration of the placenta appeared to be
progressively advanced and associated with blood
clotting, nuclear pyknosis, cell lysis and fragmentation
and aggregation of leucocytes in the maternal vessels.
The trophoblast cells became condensed or vacuolated.
The trophoblastic lamella was highly damaged, and thus
circulatory disturbances occurred. Hence, fetal death
was resulted. Beginning from the 7th day after
injection, gradual resorption and detachment of the
2placentae were observed and extensive dissolution of
tissues was found. On the 11th day, the whole placenta
was almost resorbed but cell debris still remained in the
uterine lumen. The endometrium and myometrium of the
recovered uterus showed no observable structural changes
at this time to the 25th day after X-MMC injection.
By using radioimmunoassay, it was found that after
administration ofa MMC, the CG content per placenta was
decreased compared to the corresponding control
specimen, which was probably due to reduced activity of
the trophoblastic tissue or a drop in number of living
trophoblastic cells. The decrease in CG level was more
significant (p0.05) on the 1st to 3rd day after
injection, during which the trophoblasts were in their
actively proliferating and secretory phase in the normal
pregnant mice.
Oxytocin produced dose-dependent increase in tension
of the uterus in both the control and treated groups.
The main finding was that maximum tension induced was
significantly lower in the treated group from day 11 to
day 21 after injection while the ED50 remained unchanged
for the 15-day period studied. ,It seemed that the
reduction in the maximum amount of uterine contraction in
the treated group was a secondary effect, i.e. it might
be due to normal production of oxytocin receptors near
parturition was affected because of the abortifacient
drug.
3Concerning second pregnancy, it was found that the
drug treated mice could become pregnant again. There
were no differences between the treated and control
groups with respect to the number of fetuses and the
duration for the second gestation. Hence it can be
concluded that x-momorcharin is an effective
abortifacient drug for mid-term pregnant mice and no
obvious accumulative effect can be found.
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11. INTRODUCTION
Chinese herbal medicine is an integral part of our
culture. A large portion of the Chinese population today
still depends heavily on traditional Chinese medicine for
their health care. Even in Hong Kong, where Western
medicine is readily available, many people often choose
to take Chinese medicine as an alternative to Western
medications. Recently, researchers are trying to
evaluate the true efficacy of traditional Chinese
medicines and to put them on a more scientific basis.
In the case of contraception and abortion, numerous
traditional herbs have been investigated. For male
contraceptives, gossypol is a promising drug isolated
from the cottonseed (Tang et al., 1980 Tung et al.,
1980 Shao et al.,1982). Another chelating agent called
DTPA (diethylethylenetriaminepentaacetate) has been
reported to interfere with spermatogenesis (Yu et
al.,1980).- For female contraceptives, a number of
uterotonic components have been identified, such as
leonurine from Chinese motherwort (Leonurus artemisia)
(Chan et al., 1983). The feasibility of applying the
abortifacient agents to the termination of pregnancy. has
also been extensively investigated in China. Since it is
quite dangerous to induce abortion at mid-gestation,
candidates of appropriate drugs must be carefully
selected and thoroughly tested before clinical use so
2that the health of the mother may not be jeopardized.
Abortion of unwanted pregnancies may be induced by a
number of herbal extracts, chief among these is
trichosanthin (Wang, 1985). Trichosanthin is able to
cause termination of mid-term pregnancy in mice, rabbits,
monkey and human (Wang et al., 1976a, b Chang et al.,
1979; Lau et al., 1980; Zhong and Wang, 1983; Jin, 1985
Liu et al., 1985). More recently, two proteins, c'(-
and 6-momorcharin, extracted from the seed of Momordica
charantia Linn.(Family Cucurbitaceae), known as the
bitter melon locally, have been discovered to have
abortifacient effects in mice (Law, 1983; Lau, 1983; Chan
et al., 1984a, b Yeung et al., 1985). x-momorcharin has
been fo-und to be in many aspects similar to trichosanthin
(Law, 1983; Lau, 1983; Tam et al., 1985). It'has been
shown that the drug causes terminatio-n of early pregnancy
in mouse and reduces incidence of embryo implantation
(Tam, et al., 1984). Moreover, histological changes on
4-48 hours treated placenta of mid-term pregnant mouse
have been observed using transmission electron microscopy
(Lau, 1983). However, many other aspects of the effects
of momorcharin have not been examined. For example,
whether there are any changes in the placental hormones
that can maintain pregnancy such as chorionic
gonadotropin, which acts as a placental function test for
gestational trophoblastic disease and hence can be used
as an indicator for termination of pregnancy, is not
3clear. Furthermore, it is not known whether the drug
remains in the mother mouse and exerts its effect on the
second pregnancy of-the mouse during the time course of
the recovery of the uterus after drug treatment.
Therefore, it is very important to find out if. the drug
shows any accumulative effect in the mother mouse.
While the main aims of the present investigation
were to study the mechanism of action of cX-momorcharin
through intervals after drug administration, my research
focused more on the histopathological changes of the
placenta and uterus after the administration of oC-
momorcharin with the aid of light and scanning electron
microscopy, together with the use of the other parameters
to study placental damage and recovery of the uterus so
as to give a clear picture of the drug action and explore
its potential for the development as an alternative
effective and safe` abortifacient drug. Hence, the
present studies include: (1) histological observations
of the effects oft*momorcharin on the treated mouse
placenta and uterus for a long time course, i.e. on every
alternate day from the first to the twenty-fifth day
after the drug treatment; (2) measurement of the level of
placental hormone changes to act as an indicator for
termination of pregnancy; (3) by using oxytocin to induce
the treated mouse uterus so as to find out-the recovery
of the myometrial smooth muscle cell contractility and
(4) second pregnancy test following induced abortion.
42. LITERATURE REVIEW
2.1 Placenta and Hemochorial Placentation
Defined broadly, "placenta" is the union between any
fetal structure and any part of a parental organism which
mediates physiological exchange during pregnancy. Hence,
the placental. functions are generally said to include all
physiological activities depending directly or indirectly
upon fusion and interaction of the fetal and uterine
tissues during prenatal life. Therefore, the term
"placenta" can be more specifically applied to any
intimate juxtaposition of fetal and uterine tissues
demonstrated to possess functional capabilities (Wimsatt,
1962). Placentae in which maternal blood vessels are
devoid of an endomnetrium and have direct contact with the
trophoblasts are described as hernochorial (Wynn, 1975).
2.2 The House Placenta
According to Grosser's classification, both the
human and mouse placentae are hemochorial (Wimsatt,
1962). However, the villi of mouse placenta have lost
their identity and fuse profusely to form a labyrinth in
which maternal blood flow in a countercurrent fashion
(Wiinsatt, 1962). As there is a total of three layers of
trophoblastic cells between the maternal and fetal blood
flow, the murine placenta is further classified as
5hemotrichorial or labyrinthine hemochorial placenta
(Enders, 1965; Kirby and Bradbury, 1965). This
labyrinthine placenta is formed by the 10th day of
pregnancy (Pijenborg et al., 1981). Like many other
rodents mouse possesses a high reproductive potential.
The litter size is variable, usually from 1 to 10.
Gestation in the nonsuckling mouse normally lasts 19 to
21 days (Bronson et al., 1968). Since it appears that
the mouse placenta s-eems to be identical in every aspect
with that of the rat, hamster and guinea pig (Jollie,
1964 Enders, 1965; Carpenter and Dishaw, 1979; Oduor-
Okelo, 1984), the description of the placental barrier of
these rodents can be applied to that of the mouse.
Extensive studies of the placental structure of these
rodents are available (Enders, 1965; Kirby and Bradbury,
1965; Parkening, 1976; Carpenter and Dishaw, 1979; Bell
and Searle, 1981; Scott and Pendergrass, 1981; O'Shea et
al., 1983; Bacon et al., 1984; Oduor-Okelo, 1984; Welsh
and Enders, 1987). However, among these reports there i.c
little information focusing on the three-dimensional
structure of the placenta by scanning electron
microscopy. Only the labyrinth and the decidual layer
were occasionally revealed by scanning electron
microscope (Metz et al., 1976; Scott and Penderfrass,
1981 Welsh and Enders, 1987).
2.3 Structural Aspect of the Mouse Placenta and Uterus
62.3.1 Placental Structures of Maternal Origin
a. Decidualization of the Uterus during Pregnancy
Very shortly after entering the uterus, the
fertilized eggs become spaced more or less evenly
throughout its length, and each egg finds its way into a
uterine crypt on the antimesometrial side of the lumen,
thereby coming into.close contact with the uterine
epithelium. The presence of the blastocysts quickly sets
up changes at the implantation site. Within a few hours
the epithelium begins to loosen, and its nuclei show
degenerative changes (Parkening, 1976). Within 15 hours,
it is sloughed entirely. At the same time active growth
commences in the mucosa so that by 1 day after
implantation( 5 days after mating) there is an
appreciable swelling in the uterus at the implantation
site. It is the response of the endometrial stromal
cells of the rat and mouse uterus to the implanting
blastocyst to undergo proliferation and differentiation
and result in the formation of the decidual cells of the
decidua of pregnancy. This process is known as
decidualization (Finn, 1971, 1977, 1980; Dickson and
Krcek, 1981). Therefore, a decidual cell refers
specifically to the transformed polygonal-glycogen-
containing stromal cell of the pregnant endometrium.
This swollen mucosa at the implantation site is known as
7decidua basalis (Snell and Stevens, 1968; Scott and
Pendergrass, 1981). The stromal cells in this layer
remain fibrocyte-like and are separated by wide bands of
collagen fibrils and reticular fibres. These abundant
fibrous connective tissues are thought to be accumulated
as the placenta thickens with increased gestational age
(Wynn, 1974; Bell and Searle, 1981; O'Shea et al., 1983
Parr et al., 1986). This pregnant endometrium permits
decidual tissue to: (1) effect placental separation by
the part of the decidua basalis that opposed the
myometrium is compressed into a layer of stroma which can
supply a definite line of weakness for the detachment of
the placenta from the uterus during parturition (Scott
and Pendergrass, 1981), (2) restrict trophoblast invasion
by forming a barrier to protect the myometrium of the
maternal uterus from excessive erosive activities of the
trophoblastic cells, and from destructive shearing and
tearing actions during parturition so as to keep the
myometrium functional and receptive to subsequent
pregnancy (Wynn, 1974; Welsh and Enders, 1987), and (3)
nourish the conceptus since it is rich in glycogen
secretion (Wynn, 1974; O'Shea et al., 1983).
b. Structure of the.Myometrium during Pregnancy
The myometrium of the uterus is made up of smooth
muscles closely associated with connective tissues.
During the entire course of gestation, the smooth muscles
5are responsive to hormonal stimuli to undergo hypertrophy
(Henell et al., 1983), and to nervous stimuli to
contract at the time of parturition (Leppi, 1964;
Fuchs, 1986). The hypertrophied smooth muscle cells
are rounded and much larger than ordinary ones and by
this increase in volume, the entire myometrium will be
thickened and become better supportive to the placenta
and the fetus. Each smooth muscle cell is seen closely
associated with the connective tissues. The fibres are
mainly collagenous and surround the muscle cells and
muscle bundles as sheaths for protection (Henell et al.,
1983). This arrangement of binding the muscle cells
enables the muscle to function efficiently in units of
bundles or sheets and promote the synchronization and
propagation of uterine contraction for the progression of
labor (Fuchs, 1986).
2.3.2 Placental Structures of Fetal Origin
a. The Labyrinthine Zone
The labyrinth, the spongy zone and the giant cell
layer are all of fetal origin, that is, they arise from
cells of the fertilized egg which later are attached'onto
maternal components to build up the entire functional
placenta. The labyrinth is penetrated by masses of
trophoblastic septa and fetal mesenchyme cells.
Ultrastructural observations on the labyrinthine zone
9show that fetal and maternal blood streams are closely
approximated (Oduor-okelo, 1984; Welsh and Enders, 1987)
At the stage of the blastocysts, the outer layer of cells
are the trophectoderm which will develop into the
trophoblasts.
Trophoblastic lamella which is produced by
trophoblastic septa is arranged into three-
trophoblastic layers plus a fetal endothelium. The
trophoblastic layer I is cellular while layers II and III
are syncytial in nature (Jollie, 1964; Enders, 1965; Metz
et al., 1976; Metz, 1980). It is further found that the
layer I, closest to the maternal blood space, is
fenestrated and highly permeable to all kinds of
materials. Layers II and III are very closely united
together which make them more difficult to be
distinguished as separate entities except in the region
where fenestrations occur. It is found that they are
tightly adhered by various types of cell adhesion
structures. like the tight junctions and the gap
junctions (Enders, 1965; Metz et al.,1976; Carpenter and
Dishaw, 1979; Metz, 1980). As the two layers are
relatively thicker in addition to their tight
attachment, they may direct blood flow for fetal-
maternal transport mechanisms and give structural
support (Carpenter and Dishaw, 1979; Carpenter, 1980;
Bacon et al., 1984; Parr and Parr, 1986 Welsh and
Enders, 1987). Transport across this barrier is
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made selective so that absorptive materials 6Ulu6
from the mother to the fetus and secretive materials
going back from the fetus to the mother follow a unique
pattern and balance between the two sides. In addition,
the fenestrations seen as small invaginations of
the trophoblastic layers may play a very important
role in regulating the rate of transport or they may even
be pinocytotic vesicles which carry molecules over. It
is suggested that they can provide undulations on the
trophoblasts so that maternal plasma over the region
can have their nutrients abs.orbed more efficiently
since they are trapped in stagnation (Enders, 1965
Davies and Glasser, 1968 Welsh and Enders, 1987).
b. The Fetal Endothelial Layer
Fetal endothelium bounding the fetal blood
spaces is a continuous layer. Besides, endothelium is
known to be a fenestrated attenuated layer of cytoplasm
and is similar to other endothelial cells (Jollie, 1964).
It appears that trophoblast can form junctions with
adjacent endothelial cells, but how endothelial cells are
disposed of is not obvious. The fate of endothelial
cells after they come in contact with trophoblast is not
clear (Welsh and Enders, 1987).
c. The Spongy Zone
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While the layer of trophectoderm overlying the inner
cell mass will form the fetal placenta, the rest of the
trophectoderm.will constitute the primary giant cells.
The ectoplacental cone is the ultimate source of the
fetal placenta, being further differentiated into the
labyrinth and the basal zone. The basal zone refers to
two layers, the giant cell layer and the spongy zone.
The spongy.zone is also called the junctional zone,
constituted by the spongioblasts or the
spongiotrophoblasts. Spongioblasts are small and
basophilic cytotrophoblastic cells (Davies and Glasser,
1968). The basophilia of the trophoblasts is due to the
presence of ribonucleoproteins (Deane et al., 1962).
They are not only found in the spongy zone but also in
the trophoblastic septa of the labyrinth. It is the
only group of cells that show mitosis and hence, they may
be the ultimate cells of the fetal placenta'for
generative purpose. Actually, as giant cells are seen
arising from the spongioblasts, and as the trophoblastic
labyrinthine lamellae are generated by the trophoblastic
septa, the spongy zone may be responsible for the
formation and expansion of the labyrinth and the giant
cell layer on both of its sides. Moreover, the cell is
irregular in shape which may be due to some artifacts,
membrane modifications for enzymatic or antigenic
recognitions, and endocytotic or exocytotic activities,
since the trophoblasts are known to contribute to the
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immunological aspects and hormone secretion of the
placenta (Deane et al., 1962).
d. The Giant Cell Layer
The enormous size of the giant cell may be due to
failure of cytokinesis in cell mitosis or in a junctional
zone mitosis, followed by growth and resulting in their
polyploidy condition (Dickson and Bulmer, 1960). Though
its structure is of unknown nature and function it is
believed to be associated with secretion of steroidal
hormones, and erosive and phagocytotic activities (Deane
et al., 1962).
2.3.3 Gross Morphology of the Mouse Uterus
The uterus in the mouse is Y-shaped bicornuate
tubular structure consisting of two horns uniting just
anterior to their junction with the vagina, and each
attached to the dorsal body wall by a mesentery, the
mesometrium-(Mossman, 1977). The uterine lumen is lined
with simple. columnar epithelium. Between the epithelium
and the muscle layers is the endometrial stroma which is
composed of reticular tissue with many small polyhedral
cells and lymphocytes. This endometrial stroma forms
the bulk of the uterine wall. The epithelium is
indented by numerous small crypts. Branched tubular
glands extending from the epithelium project into the
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endometrial stroma. The muscle layer of the myometrium
consists of inner circular and outer longitudinal layers
of smooth muscle with a layer of very vascular loose
connective tissue, the stratum vasculosum, in between.
The outer covering is the serosa which is continuous with
the mesometrium (Hummel et al., 1968).
2.3.4 The Recovery of the Uterus after Parturition
During pregnancy, the increase in mass of the uterus
has been accounted for mainly by hypertrophy of the
smooth muscle cells and by an increase in collagen
content.' Following parturition the uterus regains its
nonpregnant weight within little more than a week.* This
rapid decrease of the weight and collagen content of the
uterus is known as involution (Afting et al., 1979
Shimizu et al., 1985).
After parturition, autophagocytosis,
heterophagocytosis and crinophagy are likely mechanisms
for the reduction in size of the smooth muscle cells
(Henell et al, 1983). Autophagocytosis in smooth muscle
cell is a means to reduce the muscle number and size. In
some instances extensive autophagy appears to lead to
cell death. Nonetheless, the lack of morphological.
evidence for an extensive lysosomal apparatus in uterine
smooth muscle cells of the nonpregnant rat does not seem
to support the notion of autophagy as a major mechanism
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responsible for the size reduction of the cells (Henell
et al., 1983). Heterophagocytosis of smooth muscle cells
by macrophages has the ability to endocytose cytoplasm
whereas fibroblasts are mainly engaged in the digestion
of collagen and all debris including split off bits of
smooth muscle cell cytoplasm. Besides, it is found that
in mice about 90% of the uterine collagen is.resorbed
during the first 3 postpartum days (Shimizu et al., 1983
Shimizu and Maekawa, 1983 Shimizu et al., 1985) Hence,
at the time of parturition the (pro)collagen synthesized
but not yet secreted is retained within the fibroblasts
and degraded by means of crinophagy which is a means for
fibroblasts to regulate their export of collagen when
synthesis exceeds the decreased need postpartum (Henell
et al., 1983 Shimizu et al., 1985). Therefore, most of
the uterine collagen is degraded by extracellular but not
by the-intracellular pathway. Degradation,of the
extracellular excess of collagen fibers synthesized
during pregnancy may proceed by heterophagy (Parakkal,
1969 Henell et al., 1983). The collagenase activity, which
appears shortly after delivery, is maintained at high
levels throughout uterine involution and then declines to
low or undetectable levels when resorption is complete
(Jeffrey et al., 1971 Halme and Woessner, 1975 Shimizu
et al., 1985). In addition, it is found that there are
membrane-bound structures containing electron-dense
material in the cytoplasm of the smooth muscle cells of
rat myometrium. The number of such structures.
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progressively increases with gestation reaching the
maximum during parturition and decreases to a minimal
level 2 days postpartum. It is suggested that the
occurrence of these structures is of physiological
relevance in parturition and may be involved in uterine
involution (Kwan et al., 1986).
On the other hand, since the glandular tissue seems
an obvious candidate as a stem cell population for cyclic
or postpartum renewal of the surface epithelium (Finn,
1975 Leroy et al., 1981), its role deserves to be
studied from this point of view for the regeneration of
the uterine epithelium. It is found that the process of
glandular and surface epithelium regeneration not only
involves proliferation to restore topographical
relationships between glands and lumen, it also entails
differentiation of the newly formed epithelial tissue as
regards the specific role of luminal epithelial cells in
triggering the decidual reaction (Finn, 1975). Uterine
repair after experimental removal of the epithelium is
therefore functional as well as morphological like
uterine regeneration postpartum (Leroy et al., 1981).
2.3.5 The Estrous Cycle 'of the Mouse and the Corresponding
Vaginal Smear Observations
Knowledge of the estrous cycle in the mouse dates
from the classic study by Allen (Bronson et al., 1968).
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Unless interrupted by pregnancy, mice normally tend to
display signs of estrus, including mating behavior, every
4 or 5 days. The mouse therefore is a polyestrous
mammal. The mouse estrous cycle has been divided into
four phases: proestrus, estrus, metestrus, and diestrus.
To detect changes in the cycle, the vaginal smear
technique can be applied in which the vaginal content is
obtained and spread on a microscopic slide for
examination of its cell type composition. Vaginal smears
may be obtained by flushing the vaginal content out with
a few drops of physiological saline using a dropper
(Nicholas, 1967).
Cellular characteristics of vaginal smears reflect
changes in the structure of the vaginal epithelium which,
in turn, are dependent upon estrogen and follow a regular
and predictable course during the cycle. Three types of
cells are found in vaginal smears: leucocytes, cornified
epithelial cells, and nucleated epithelial cells.
Relative abundance of the various types of cells during





few irregular cornified cellsEstrus
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numerous cornified cells mayMetestrus
form continuous sheet and some
leucocytes
many leucocytesDiestrus
Therefore, as estrus approaches, the smear may contain
epithe Lial cells-with dark-staining cytoplasm and
karyolytic nuclei. Cells intermediate between cornified
and nucleated epithelial cells also occur. It should be
noted that the smear marking the termination of estrus is
often denoted by the presence of clumps or sheets of
cornified cells (Nicholas, 1967; Bronson et al., 1968
Van Tienhoven, 1968).
2.3.6 Cyclic Structural Changes of the Uterus
a. General Appearance of the -uterus during 1strous Uycle
In general appearance, the uterine wall is distended
because of the activity of the uterine glands in
proestrus and estrus. The distension starts to-diminish
in late estrus, and in diestrus the uterine wall is
collapsed. Glycogen content is greatest at proestrus
and the uterine epithelium is composed of low columnar
cells with maximal mitotic figures in estrus. In
metestrus, degenerative processes become apparent. The
basement membrane fades into a pink-staining band which
includes the basal sides of the epithelial cells and the
superficial stroma. The epithelium loses its definite
organization and shows vacuolar degeneration. Leucocytes
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appear in the-region of the basement membrane whereas the
degeneration of the epithelium is further advanced, so
that almost all the epithelial cells are lost and
leucocytes are numerous. The uterine glands show
minimum activity. The onset of diestrus is marked by the
beginning of regenerative processes.
b. The Cyclic Changes of the Uterine Epithelial Surface
Ovarian hormonal influence upon the uterus can be
ascertained by examination of the ultrastructure of the
endometrial luminal surface which undergoes morphologic
alterations with fluctuation in hormone.level (Finn and
Martin, 1974 Craig and Jollie, 1984). In addition,
epithelial surface ultrastructure of the uterine lumen-at
the implantation site has been characterized in the young
rodent during the estrous cycle'(Anderson et al., 1975
Lamb et al..,. 1978).', the artificially induced decidual
reaction (Craig and Jollie, 1981), and at different
typical hormonal levels.(-Murphy et al., 1979 Williams
and Rogers, 1980 Murphy-et*al., 1981, II, III Tachi,
1984). Moreover, tight junctions between uterine luminal
epithelial cells undergo changes both in structure and
organization when exogenous ovarian hormones are
administered to ovariectomised'rats and in-normal stages
of pregnancy in rats (Murphy et al., 1980,1982 a,b).
As observed by scanning electron microscopy,
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transverse ridges formed by the endometrium is composed
of luminal epithelial cells covered with apical
microvilli. The surface ultrastructure and size of the
endometrial cells varies with the state of reproductive
cycle and onset of implantation (Walker, 1960;
Bertalanffy and Lau, 1963; Jones and Hamer, 1975; Lamb et
al., 1978; Corbeil et al., 1985). These epithelial
cells are characterized by apical microvilli, and the
abundance and length of these microvilli vary throughout
the reproductive cycle (Walker, 1960; Bertalanffy and
Lau, 1963; Lamb et al., 1978; Corbeil et al., 1985).
Besides, some endometrium convolutions show a 'pin-
cushion' effect, and the "studs" may probably represent
dead or dying epithelial cells which have been extruded
from the surface (Jones and Hamer, 1975). There is no
striking difference between the surface_ultrastructure of
the luminal and glandular epithelia of the endometrium
except that there are papilla openings which are the
exits of the uterine glands (Enders and Nelson, 1973
Jones and Hamer, 1975).
The microvilli of endometrial cells appear to be
moniliform in the mouse (Jones and Hamer, 1975). At low
magnification, endometrial changes which are visible
include the increase in the width and height of the
transverse uterine folds in proestrus, early estrus and
estrus by comparison, during metestrus the uLer.ine folds
appear rough, broken and shallow whereas the folds appear
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smooth but still quite shallow during diestrus (Lamb et
al., 1978). At higher magnification, the diestrous
uterine epithelial cells have short stubby microvilli and
occasional long microvilli (Lamb et al., 1978 Corbeil et
al., 1985).. By proestrus, glandular. openings are
prominent. The cells are covered with dense microvilli
of. approximately equal length-since the long microvilli
seen in diestrus are no longer present. Small secretory
granules are found in the apical portions of the cells
and microvilli are surrounded by secretory products
suggesting a recent burst of secretory activity (Corbeil
et al.,'1985). The uterine folds are prominent
structures at estrus with readily apparent glandular
openings '(Jones and Hamer, 1975 Lamb et al., 1978). In
both stages, the rounded apical cell surfaces have fairly
long microvilli which are of a homogeneous length
and the cell surfaces project into the uterine lumen,
as-in,proestrus. Fuxe and Nilsson (1963) have examined
the ultrastructure of the mouse uterine epithelium
and have confirmed that maximum secretory activity
occurs at estrus. The uterine glands are not as easily
located at metestrus. The epithelial cells are
degenerative with cell protrusions visible (Lamb
et al., 1978). Some cell surfaces have few or no
microvilli and cells are. seen free in the uterine lumen.
The uterine epithelium is disrupted with swollen cells,
blebs, and areas denuded. of microvilli. Debris on the
surface is common (Corbeil et al., 1985). Therefore, the
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uterine epithelial cells are found to have rounded
surfaces throughout the cycle but the length and
uniformity of microvilli vary from short and evenly
distributed at proestrus/estrus, to short with denuded
areas at metestrus, and to a mixture of short and
occasional long microvilli at diestrus (Lamb et al.,
1978; Corbeil et al., 1985).
c. Functional Significance of Cyclic Changes of the
Surface Structure
The functional significance of the structural changes-
in the apical microvilli is unknown. It is possible that
these changes in the microvilli are related to cyclic
changes in the localization of alkaline phosphatase in
cell membranes (Hafez and Ludwig, 1977). In aged mice
with apparently functional corpora,lutea but no decidual
swellings, the luminal region of the uterine epithelial
cells has tall microvilli, as in the "preattachment
stage" (Smith, 1975; Craig and Jollie, 1984). The length
of endometrial microvilli increases with estrogen and
conversely decrease as progesterone levels increase
(Nilsson, 1966; Anderson et al., 1975). This enhancement
of uterine cell surface may be necessary to augment
absorption by the epithelium or to increase transport-of
electrolytes for metabolism (Anderson et al., 1975). It
appears that failure of the luminal epithelium to respond
to estrogen may be one of the causes of implantation
22
failure in aged female rodents since the changes in the
uterine cell membrane, including the microvilli and the
glycoprotein secretion, may increase cell adhesiveness
which can play a role in blastocyst implantation or also
promote sperm transport or capacitation of sperm before
fertilization (Nilsson, 1966 Corbeil et al.. 1985).
2.4 Chorionic Gonadotropin during Pregnancy
2.4.1 Changes of Mouse Chorionic Gonadotropin
Hormonal Level during Gestation
It is known that high levels of progesterone,
estradiol and chorionic gonadotropin are necessary to
maintain pregnancy. When the levels of these hormones
fall, abortion ensues. Besides, prostaglandins may help
parturition. However, the relationship of hormones during
parturition is only partially worked out (Diczfalusy,
1974 Embrey, 1981). The presence or not of a placental
gonadotropin in the rat and mouse has been a matter of
controversy (Linkie and Niswender, 1973 Chowdhury and
Steinberger, 1976). Using a radioimmunoassay for human
chorionic gonadotropin, a significant activity in
acetone-ether extracts of rat, mouse and hamster
placentae are shown. It indicates that rodent placentae
contain a chorionic gonadotropin and that this hormone
and its alpha- and beta-subunits are structurally similar
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to their human counterparts (Wide and Hobson, 1977 Wide
and Wide, 1979 Wide et al., 1980). Mouse chorionic
gonadotropin level can-be detected in all pools of
implantation sites and placentae. It is found that there
is a rapid rise-in the chorionic gonadotropin content
from day 5 until a maximum level is reached on day 11. A
nadir-is then found on day 14 and a second, but lower,
peak on day 16 is followed by a decline during the last
2 days of pregnancy (Wide and Wide, 1979) Besides,
Linkie and Niswender (1973) use a bioassay to-show
detectable levels of a "luteatrophic factor" in the rat
placenta on days 11, 12 and 13 with a maximum on day 12.
This indicates that the peak values for the placental
gonadotro.pin in the mouse occur at a stage of pregnancy
similar to that in the rat (Wide and Wide, 1979).
2.4.2 Functions of.Chorionic Gonadotronin during Gestation
It is known that, in the mouse, ovariectomy at any
time during pregnancy results in termination of
gestation, while hypophysectomy can be performed after
the eleventh day of pregnancy without disturbing
pregnancy (Wide and Wide, 1979). It has been
demonstrated. that the hormone chorionic gonadotropin
secreted by the trophoblastic cells of the placenta
(Midgley and Pierce, 1962), and its production is
autonomous and related to the changing ratio of cyto- to
syncytio-trophoblasts or the existence of placental
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inhibitors and stimulators (Wilson et al., 1980 Morrish
and Siy, 1985; Belisle et al., 1986). It keeps the
corpus luteum functional until the steroid hormones
(progesterone and estrogen) required for the development
of the fetuses are produced in sufficient amounts by the
feto-placental unit to sustain pregnancy (Diczfalusy,
1974).
During early gestation, the steroid hormones needed
to initiate and maintain pregnancy are produced by the
corpus luteum, whose activity is stimulated by chorionic
gonadotropin. Obviously, any inhibition of chorionic
gonadotropin activity should result in the prevention or
disruption of pregnancy. Besides this luteotropic
effect, chorionic gonadotropin also enhances progesterone
formation in the placenta (Rice et al., 1964) and
conversion of estradiol to estriol (Troen, 1961).
It has also been demonstrated that quantitative
measurement of chorionic gonadotropin can serve as a
useful prognostic indicator for abortion (Mishell and
Davajan, 1966; Braunstein et al., 1978; Milwidsky et al.,
1978). Chorionic gonadotropin level can act as a
placental function test for gestational trophoblastic
diseases as hydatidiform mole and ectopic prdgnancy
(Pattillo and Hussa, 1984; Steier et al., 1984). An
increase of chorionic gonadotropin signifies an increase
in tissue mass, whereas decreased value indicates a
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reduced placental mass or abnormal trophoblastic function
(Braunstein, 1978; Klopper, 1980). However, there is no
evidence that such a fall in chorionic gonadotropin
concentration is causative of the abortion or indeed
precedes.the placental damage (Klopper, 1980, Pattillo
and Hussa, 1984). Cytogenetic abnormalities of the
abortuses seem to suggest the hormone deficiency is the
consequence of secondary changes due to decreased
viability or death of the products of conception
(Benirschke and Driscoll, 1974). This may finally lead
to abortion. However, it is found that the disappearance
rates of human chor-ionic gonadotropin in women of legally
induced abortion has a long time span. This may be due
to a combination of factors, including the storage of
human chorionic gonadotropin in tissue and the renal
clearance rate of human chorionic gonadotropin. However,
it may also signify. continued production of human
chorionic gonadotropin from functioning trophoblastic
tissue-for some time.after abortion (Steier et al.,
1984).
2.5 Oxytocin-induced Uterine Muscle Contraction
2.5.1 Uterine Muscle Contraction During Reproductive Cycle
It is known that the uterus undergoes a cyclic
sequence of changes-characterized by distinct
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ultrastructural changes and variation in myometrial
contractile response. During estrus, the frequency of
spontaneous uterine contraction is low and the amplitude
is large (Roberts, 1977). At this phase, under the
influence of estrogen the myometrium exhibits greater
spontaneous contractile activity as well as enhanced
sensitivity to stretching and external stimuli (Soloff,
1975 Riemer and Roberts, 1986). The diestrus phase then
continues to produce estrogen while markedly increasing
its synthesis of progesterone. Myometrial contractile
activity during this phase is characterized by a decline
in frequency, while amplitude remains low. The influence
of progesterone on the myometrium diminishes excitability
and the propagation of excitation stimuli (Riemer and
Robe-rts,_.1986). Upon fertilization and implantation of
an ovum in the uterus, the major site of estrogen and
progesterone synthesis shifts from.the ovary to the
placenta. The levels of estrogen (primarily estriol) and
progesterone in myometrium increase throughout the
course of pregnancy until just prior to parturition when
progesterone levels decline precipitously while estrogen
levels continue to rise. The high-estrogen levels
during pregnancy promote uterine hypertrophy (Leppi,
1964; Henell et al. 1983) Fuchs, 1986) and maintenance
of high levels of contractile proteins as well as
increasing myometrial sensitivity to the neurohypophyseal
hormone oxytocin (Soloff, 1975; Nissensen et al., 1978).
However, the estrogen-induced enhancement of spontaneous
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contractile activity is suppressed, apparently because
the, concentration of progesterone in myometrium is also
high.
With the onset of labor, myometrial sensitivity to
oxytocin is at its highest level in the reproductive
cycle. It is clear that this hormone can enhance the
amplitude, frequency, and resting tonus of myometrium,
and that estrogen increases myometrial sensitivity to its
effects (Riemer and Roberts, 1986).
2.5.2 Mechanism of Oxytocin Induced Uterine Contraction
Oxytocin stimulates uterine contractility as it acts
by increasing the level of ionized calcium in the
cytoplasm. The principal response is an increase in
intracellular calcium ion concentration which is mediated
through an influx from the extracellular space and/or
release from subcellular calcium stores (Sakai et al.,
1982; Ashoori et al., 1985). Oxytocin is the most potent
agent known to elicit uterine contractions (Heap, 1983
Ladosky and Calixto, 1984). The threshold concentration
for in vitro stimulation of estrogen-primed rat uterus is
5 to 30 uU/ml (Fitzpatrick and Bentley, 1968).
It is found that estrogen increases the number of
specific binding sites for oxvtocin in rat and rabbit
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myometrium while having apparently no effect on the
affinity of the receptors (Nissensen et al., 1978). The
number of oxytocin receptors increases dramatically over
a short period of time. The increase in sensitivity to
oxytocin, (i.e., leftward shift of oxytocin dose-response
curve) has been attributed to the increased number of
receptors (Fuchs, 1986).
2.5.3 Oxytocin Binding Sites in the Uterus
Soloff et al. (1975) have demonstrated the presence
of specific binding sites for oxytocin and characterized
the binding sites with respect to affinity and
specificity. The binding affinity of various oxytocin
analogs correlates, in general, with their potency as
agonists or antagonists, and factors that affect the
binding of oxytocin affect the biological response in the
same way. The fraction containing the binding sites is
further purified, and the myometrial.oxytocin receptors
are, located on the plasma membrane of the smooth muscle
cell.. The turnover of receptors appears to be relatively
rapid, judging from the decline in receptor numbers
following parturition or hormone withdrawal (Soloff et
al., 1975; Fuchs, 1986).
In pregnant rats the number of myometrial oxytocin
receptors and the sensitivity to oxytocin rise sharply at
the time of parturition. The increase in oxytocin
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receptor concentration in the pregnant rat uterus may
therefore be the factor that precipitates the onset of
labor, since plasma oxytocin levels do not rise
significantly until advanced labor. The distribution of
oxytocin-receptors within the uterus provides a
biological basis for the directional organization of the
forces generated by the contractions and partially
explains why during labor the lower segment remains
passive, whereas the upper segment undergoes active
contractions (Fuchs, 1986).
In addition to the myometrium, oxytocin receptors
were also found in the endometrium of nonpregnant uteri
and in the decidua parietalis (not in the decidua vera)
(Hall, 1983). The concentrations were similar to those
in the myometrium, including the rise at the time of term
of preterm labor. Decidual cells are not contractile
cells, and the function of the oxytocin receptors in
decidua is, therefore, obscure. It is suggested that
these receptors mediate an interaction between oxytocin
and'the synthesis of prostaglandins in the decidual
cells (Fuchs, 1986).
Therefore, the stimulation of uterine contractions
during spontaneous labor results from a combined action
of oxytocin and prostaglandins. Recent evidence suggests
that oxytocin is more important for the initial phase of
labor, whereas prostaglandin Fza seems to be essential
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for the progression of labor and cervical dilatation
since oxytocin stimulates in vitro prostaglandin F2x
production during labor (Chan, 1983; Heap, 1983; Fuchs,
1986). Nonetheless, the formation of gap junctions
between the myometrial cells is probably also essential
for the synchronization of myometrial activity and,
hence, for the progression of labor (Riemer and Roberts,
1986). The timely coordination of myometrial events with
respect to the oxytocin receptors, the gap junctions, and
the synthesis of prostaglandins is probably the key
factor to the initiation and maintenance of spontaneous
labor.
2.6 The Abortifacient Drug- X-Momorcharin
2.6.1 Functions of the Chinese Herbal Medicine,
Momordica charantia
Momordica (Cucurbitaceae family), the bitter melon, is
a kind of vegetable which is widely grown and consumed in
the Orient. However, only a limited number of
investigations has been devoted to the isolation of the
potential bioactive ingredients in the plant.
In China, M. charantia has long been shown to be an
effective medicinal herb for various diseases by using
various parts of the plant. It is found that they are
able to cure dysentery, heartstroke, skin ulcers and
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stomach cramps. They are also general febrifuges and
have strong antipyretic actions against the various
discomforts of the febrile symptoms (Anonymous, 1978).
However, the fruit also shows toxicity in the rat, the
rabbit and other animals. It can cause uterine
hemorrhage and death of a pregnant rat in a few hours
after 6 ml extract/kg body weight is administered orally
(Anonymous, 1978). The seeds are bitter, nontoxic and
may increase male fertility, or make the body healthier
(Li, 159,6).
Modern studies show that the fruit extract is used
as hypoglycemic agents (Akhtar et al., 1981), purgatives,
emetics and abortifacients (Vesely et a1.,1977). These
properties may be attributed to a guanylate cyclase
inhibitor which has been partially purified (Vesely et
a1., 1977). The extract may also, cause testicular
malfunctioning in -the dog, thus inducing infertility by
antispermatogenicity without altering the general
metabolic activities (Dixit et al., 1978). The crude
extract of M. charantia has also been reported to be a
glycoprotein which has cytotoxic and cytostatic
activities on human lymphocyte (Takemoto et al., 1982).
Various bioactive factors from the seeds of M.
charantia have been extracted. These include two
tetrameric storage proteins rich in glutamic acid,
glutamine and arginine (Li, 1977), two glycoproteinaceous
32
lectins of which one is a toxic momordin shown to inhibit
protein synthesis of Ehrlich ascites tumor cells and the
other is a nontoxic momordica agglutinin demonstrated to
agglutinate human blood cells (Lin et al., 1978), two
other lectins,-both composed of two subunits (Li, 1980),
a haemagglutinating lectin which is a potent inhibitor of
protein synthesis in a cell free system, the rabbit
reticulocyte lysate (Barbieri et al., 1979,1980; Gasperi-
Campani et al.,1980) and which may be similar to a D-
galactose binding lectin reported (Horejsi et al., 1980),
and finally the M. charantia inhibitor, a very potent
protein synthesis inhibitor of the lysate system
(Barbieri et al., 1980) and a ribosome inactivator
(Falasca et al., 1982).
2.6.2 Purification and Functions of X-Momorcharin
Until recently, two new abortifacient proteins, X-
and(- momorcharin have been isolated from the seeds of
M. charantia (Law, 1983; Yeung et al., 1985). The
extraction process first involves homogenization of the
decorticated seeds. Then, after the homogenate is
filtered and centrifuged, the supernatant is subjected to
acetone fractionation twice, to obtain AP I extract and
AP II extract respectively. The AP II extract is further
purified by ion-exchange chromatography to yield C5 and
C6 extracts which after running through the gel filtra-
tion column give two active abortifacient proteins, cX-
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and R-momorcharin respectively.
cK-momorcharin is found to be a single polypeptide
chain with a molecular weight of between 27,500 to
31,000. There are no intrachain disulphide linkages.
The protein is rich in aspartic acid, glutamic acid,
alanine and leucine with carbohydrate moieties (Law,
1983 Yeung et al., 1985). It has been shown to be
effective in causing mid-term termination of gestation in
the mouse (Law, 1983), and in inhibiting blastocyst
implantation (Law et al., 1983; Tam et al., 1985). It
has also been found that a-momorcharin causes termination
of early pregnancy in the mouse and reduces incidence of
implantation, whether the embryo is treated in vitro or-
in vivo (Tam et al, 1984a, bTam et al., 1985).
Partially purified extract like AP II extract and C5
extract are also mid-term abortifacients in the mouse
(Lau, 1983; Law, 1983). The histopathological studies of
mouse placentae treated with C5 extract using the
transmission electron microscope have been reported (Lau,
1983). Besides, the AP II extract has also been shown to
be effective in mid-term abortion in rat (Ooi et al.,
1986) and the histological changes in the rat placenta
using the light microscopy and scanning electron
microscopy have been observed.
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3. MATERIALS AND METHODS
The ICR mice of 10 days of pregnancy (PD 10)
supplied by the Animal House of The Chinese University of
Hong Kong were used in this investigation. The day of
occurrence of vaginal plug was assigned as day one of
pregnancy (PD 1). 'Purified white powder of X-momorcharin
was kindly supplied by Dr. H. W. Yeung of the Chinese
Medicinal Material Research Centre of the University.
3.1 Light and Scanning Electron Microscopic Studies
The drugs were solubilized in physiological saline
(see Appendix) at concentration of 0.5mg/ml saline. The
body weight of the mice were first taken. The drug was
administered intraperitoneally.into the 10th day pregnant
(PD 10) mice with a dosage of 0.2mg/25g body weight.
Controls were done in-exactly the same manner except that
the injected material contained only physiological
saline. Three treated mice were sacrificed by ,cervical
dislocation on the first, third, fifth,-seventh,.,,,,,,
twenty-fifth day after the injection while the control
mice were killed on the first day to the seventh day after
the saline administration. Before the mice were sacrificed,
the-hormonal state was checked by examining the vaginal
smear. In addition, control non-pregnant mice at the
four different stages of estrous-cycle (i.e. proestrus,
estrus, metestrus and diestrus) and control mice just
35
after parturition (i.e. on the 20th day after mating)
were sacrificed as reference for the study of the
recovered uteri of the treated mice.
The bicornuate uterus of the mouse was dissected out
and washed with physiological saline. The uterus was
then cut open to count the number of dead fetuses and
record other gross changes. If the placentae were
reabsorbed, the whole uteri were used for fixation. The
placentae and the uteri were then processed for both
light and scanning electron microscopy.
3.1.1 Tissue Preparation for Light Microscopic Study
The placentae and uteri were first fixed in Bouin's
fluid (see Appendix) and then cut into small pieces for
dehydration through the upgrading series of ethanol and
clearing with xylene. Then, paraffin (paraplast, melting
point 56-57°C) was used in infiltration and embedding.
The blocks were trimmed and were sectioned at a thickness
of 5 micron by microtome (Zeiss). These sections after
adhering onto microscopic slides, were deparaffinized
with xylene and gradually hydrated with descending series
of ethanol. They were then stained with hematoxylin and
counterstained with eosin (see Appendix). The slides
were dehydrated and cleared. After mounting with
Canadian balsam (see-Appendix), they were ready for light
microscopic observations. Photomicrographs were taken
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with a Nikon UFX microscope equipped with a Nikon FX-35
camera.
3.1.2 Tissue Preparation for Scanning Electron
Microscopic Studv
The placentae and uteri were dissected out from the
mice and washed with physiological saline. Then, they
were fixed'in 2% glutaraldehyde in cacodylate buffer (see
Appendix) at pH 7.3 at 4°C for half an hour and then
further cut into smaller pieces which were fixed again
in the same gluteraldehyde for several days. Following 2
changes of buffer wash, the tissues were postfixed with 1%
.o-s-mium• te-troxide (0s04- in cacodylate buffer) (see Appendix)
for two hours at ice cold temperature. They were then
partially dehydrated. with the upgrading series of ethanol.
The placentae were-freeze-fractured by liquid nitrogen.so
as-to study the internal morphological changes. whereas
the uteri were used only for the study of epithelial.
surface alterations. These tissues were then thoroughly
dehydrated. After substitution by three changes of amyl
acetate and critical point drying by liquid carbon
dioxide, the tissues were, mounted on metal stubs by
conductance silver paint with the fractured' surface
and the epithelial surface-of the uteri exposed on top.
They were coated with palladium-gold in a rotary high
vacuum evaporator and were ready for scanning electron
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with a Nikon UFX microscope equipped with a Nikon FX-35
camera.
3.1.2 Tissue Preparation for Scanning Electron
Microscopic Study
The placentae and uteri were dissected out from the
mice and washed with physiological saline. Then, they
were fixed in 2% glutaraldehyde in cacodylate buffer (see
Appendix) at pH 7.3 at 4°C for half an hour and then
further cut into smaller pieces which were fixed again
in the same gluteraldehyde for several days. Following 2
changes of buffer wash, the tissues were postfixed with 1%
osmium tetroxide (0s04-in cacodylate buffer) (see Appendix)
for two hours at ice cold temperature. They were then
partially dehydrated with the upgrading series of ethanol.
The placentae were-freeze-fractured by liquid nitrogen.so
as to study the internal morphological changes whereas
the uteri were used only for the study of epithelial..
surface alterations. These tissues were then thoroughly.
dehydrated. After substitution by three changes of amyl
acetate and-critical.point drying by liquid carbon
dioxide, the tissues were, mounted on metal stubs by
conductance silver paint with the fractured'surface
and the epithelial surface-of the.uteri exposed on top.
They were coated with palladium-gold in a rotary high
vacuum evaporator and were ready for scanning electron
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microscopic observations. The specimens could be
photographed with JOEL-JSM-35 scanning electron
microscope, operated at accelerating voltage of 15 kV in
an ACB autoscan.
3.2 Radioimmunoassay of Chorionic Gonadotropin Level in
Mice
At least 5 ICR pregnant mice in each group were
given intraperitoneal injections at 0.2mg/25g body weight
on the 10th day of pregnancy (PD 10). The animals were
sacrificed on the first day and alternate days after the
drug administration (i.e. the 1st, 3rd, 5th and 7th day
after the inj-ection). The average weight per placenta,
percentage of viable embryos were recorded. The
placentae were then homogenized by polytron with 3 nil
diluent buffer from the RSL Quan-Preg TM- 125 I kit
(Radioassay Systems Laboratories Inc.,-see Appendix).
The homogenates were kept frozen and were ready for
radioimmunoassay. The kit for the radioimmunoassay of the
human serum or plasma of the (3-subunit of chorionic
gonadotropin (hCG-beta) was employed to detect for
chorionic gonadotropin in mice placental extract.
Since the kit was made specially for human chorionic
gonadotropin, mouse chorionic gonadotropin might not
cross react with the antibody raised against hCG.
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Therefore, the percentage binding curve of varying
amounts of mouse placental extracts must be shown-to-be
parallel to the standard binding curve. This
demonstration of parallelism was done before the assay
and-it gave confidence in the use of this kit to detect
mouse chorionic gonadotropin.
All the reagents used for the assay were brought to
room temperature prior to use. Diluent buffer, hCG-
standards, serums, antiserum and hCG- 11.5 I were. added
to 10X75 mm disposable tubes in duplicates, following the
order as shown in the table below and the mixtures were
then incubated at 37°C for two hours.
Tubes Volume of Volume of Volume of Volume
Diluent(ml) S tandard(ml) anti-hCG(ml) hCG- 26 I
ml
Blank 0.2 0 0 0.
0 0.1 0.10 0.1
•0.10.5 0 0.1 0.1
1.0 0.10 0.1 0.1
2.5 0.10 0.1 0.1
.05 o.10.1 0.1
10 0.10 0.1 0.1
25 0.10 0.1 0.1
0 0.1sample 0.1 0.1
At the end of incubation, 0.5 ml of the second
antibody (precipitant solution) was added to all tubes.
The tubes were immediately vortexed and brought to
centrifuge at 1050 Xg for 15 minutes at 4°C. The
supernatant, with the unbound labelled and unlabelled
antigen, was decanted and the pellet, consisting of all
the bound antigen-antibody complex, was counted for
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radiation in a gamma counter (LKB-Wallac MiniGamma 1275).





where CPM= average counts per minute.:. obtained in the
duplicates
sample= particular serum or standard being calculated
blank= blank tube, or non-specific binding tube
0 standard= 0 tube, or 100% binding. tube
The percentage bound was plotted against the hCG
standards to yield the standard curve, from which the
sample value could be read against.
3.3.Study for the Contractile Response of the Isolated
Uterus to Oxytocin
At least 3 ICR pregnant mice (PD 10) in each group
were administered with 0.2mg a -momorcharin/25g body
weight. On the 11th day and every alternate day till the
25th day after- the injection, the mice were sacrificed
for the in vitro uterine contractility study. The two-
horns of the uterus were dissected out and put into Van
Dyke-Hastings solution (see Appendix). Each horn was
then cu.t open longitudinally at the mesometrial side to
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give two strips of uterus. At this time, the embryos and
placentae of the treated mice were partially or
completely reabsorbed while the control mice had been
parturited. These treated mice were known to be aborted
since the placental scars could be observed. The body
weight of these mice were also recorded. In the control
group, the fetuses were born and all were viable.
Both ends of the isolated strip of uterus were
attached to a thread and put vertically into the 20-m1
organ baths which was filled with Modified Van Dyke-
Hastings solution. It was well-aerated with 95% oxygen
and 5% carbon dioxide. One thread was attached to a-
fixed pin and-the other to a myograph,: (Narco.F-60) which-
was fitted with a physiograph (Narco Biosystem MK-4).
The temperature was kept at 32°C by means of a
circulating-water bath. At least 6-samples of the
control and treated group were used in this experiment.
The preparation was equilibrated in the buffered solution
fora period of time and the resting tension was adjusted
to 0.2g before starting the experiment. Then dose-
response curves for oxytocin were constructed using the
concentration of dosage from 0.00015 U/ml to 0.5 U/ml.
The maximal response.(Emax), concentration of•oxytocin
which produced 50% of the maximal effect (ED50) and,its
log value (LogED50) were determined for each dose-
response curve. The Emax was determined by double
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reciprocal plot. Statistical comparisons were made on
Emax and LogED50 between control and treated groups. The
ED50 were finally.expressed as mean log ED50+ S.E.M. by
averaging the logED50 values obtained.
3.4 Test for Second Pregnancy in the pC-Momorcharin
Treated Mice
Four pregnant (PD10) ICR pregnant mice were
administered with OC-momorcharin on a dosage of 0.2mg/25g
body weight on PD10 while the control group were injected
with physiological saline at the same dosage. Two male mice
were put into their cage on the first day after the
injection. From this day on, the female mice were checked
on the next morning if they have had a white vaginal.plug.
It was referred to be the first day of the second pregnancy
if vaginal plug appeared. After parturition of this second
pregnancy, the number of-fetuses were also counted.
3.5 Statistical Analysis
Statistical significance of differences between
control and. treated mice of the above experiments were
determined by student's t'test for group differences and
P=0.05 was taken as the level of significance.
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4. RESULTS
4.1 Gross Changes in the a-Momorcharin Treated Pregnant
Mouse
When the mouse was treated with a-momorcharin, a
number of gross changes could be found. There was always
a loss in body weight of the treated mouse while there
was'an increase in body weight of the control at the
gestational period. Percentage of dead fetuses,
determined by the criterion of heart-beat and signs of
resorption of the fetuses, was increased in the treated
group as compared with the control (Table 1). Uterine
hemorrhage, which was referred to as the discovery of
b Lood in the uterine cavity when it was slit open to
reveal the placenta, could be observed on the first day
after the administration of m-momorcharin. Moreover, the
degree of damage in each placenta and rate of the
recovery of the uterus were different.' When the
placentae and the fetuses were examined, it was found
that they turned into dark-red or yellowish color from
.the 5th day after drug treatment. The fetuses and
placentae would gradually be reabsorbed by the maternal
uterus from this day onwards. In addition, a reduction
in weight of the placenta in the treated group was also
noticed (Figure 1). A marked decrease in placental
weight was found at the third day after drug treatment.
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These were designated as signs of resorption and all these
changes were absent in the control.
After ck-momorcharin was administered, the mouse was
left undisturbed for the study of the recovery of uterus.
It was found that the mouse did not give birth to any
young when its gestation period should have terminated
while the control mice gave birth after 19 days of
gestation. Upon dissection, masses of structureless
material were found'in the uteri of the treated mother
mice on the 5th day and onwards after the drug injection.
These structureless materials were believed to be
disintegrated and decaying products of the placentae and
fetuses. However, these masses of tissue were
reabsorbed and degenerated gradually by the mother mouse
on the 11th day after the treatment, but the placental
scars still remained on the uterus.
4.2 Light Microscopic Observations, of the Control Mouse
Placenta at Mid-Term Gestation and Uterus during the
Estrous Cycle
4.2.1 The Mouse Placenta
Despite of the increases in sizes, the cross-section of
the mouse placenta exhibited similar appearances from the
1st to the 7th day after saline injection. It showed
layers with the labyrinth outermost and the decidua
basalis innermost. Between these two layers was the
spongy zone which was next to the labyrinth and the
giant cell layer. The giant cell layer was adjacent to
44
the decidua. The whole placenta was disconnected from
the maternal myometrium by a thin layer of connective
stroma (Figure 2).
Maternal blood entered the placenta from sinuses in
the decidua to the labyrinth. Hence the labyrinth was
the place where-maternal blood spaces were separated from
the.fetal blood spaces by the trophoblasts. There were
two kinds of trophoblasts. One was the trophoblastic
septa which was composed of small basophilic
cytotrophobiastic cells with frequent occurrence of
mitotic.-figures. The other was the trophoblastic lamella
which acted to disunite the fetal and maternal spaces.
These trophoblastic lamellae were generated by. the
trophoblastic septa. Fetal blood spaces were bound by a
fetal endothelium while maternal blood had direct contact
with the trophoblast.s (Figure 3).
The spongy zone was constituted by-spongioblasts
which were small basophilic cytotrophoblastic cells,
giving rise to the labyrinthine trophoblasts and the
giant cells on both sides (Figures4, 5). The giant cell
'layer consisted of very large spindle-shaped cells
(Figure 5). The decidua basalis was a very thick layer,
about 1/3 of the 11th day mouse placenta (Figure 2). It
was of maternal origin and was made up of compact rounded
and vacuolated cells. The decidual vessels did have an
endothelium in this region (Figure 6).
45
The stroma was made up of connective tissues ana was
the line of fusion of the placenta to the uterus (Figure
2). Beyond the stroma, there was myometrium of the
uterus containing hypertrophied smooth muscle cells and
bundles of connective tissue among them (Figure 7).
4.2.2 The Mouse Uterus during the Estrous Cycle
The cross section of the mouse uterus was composed
of two layers, the endometrium and myome-triumr The
endometrium consisted of a simple columnar epithelium.
The endometrial stroma was composed of reticular tissue
containing many small'polyhedral cells and lymphocytes.
Tubular glands were observed projecting into the stroma
(Figures 8, 9, 10, 11). The myometrium consisted of
inner circular and outer longitudinal layers of smooth
muscle with the stratum vasculosum, a .layer of very
vascular loose connective tissue, between (Figure 12).
At the proestr.ousphase, there appeared to be
increasing hyperemia as prominent blood vessels were
found. Distension of the uterus was observed. Active
mitosis in epithelium and few leucocytes were shown
(Figure 8).
At estrus, it was found that the uterus was composed
of low columnar cells. The uterine glands were
prominent. Distension and mitotic activity reached
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maximum and no leucocytes could be found (Figure 9).
While at metestrus, the distension of the uterus
decreased. Some epithelial cells even showed sign of
degeneration, and as a result, the epithelium lost its
definite organization. Mitosis was rare and the uterine
glands showed minimum activity (Figure 10).
. Later at diestrus, regenerative processes began.
The-epithelial cells were healthy and mitotic activity
was observed. Many leucocytes between the stroma cells
could be observed. Besides, some secretion by uterine
glands were found at the lumen (Figure 11).
From the cross section of the uterus just after
parturition, it seemed to be different from the normal
one since large sheet of smooth muscle layer was shown to
be distended with many deep foldings (Figure 13).
Moreover, the crypts formed by the epithelial cells were
highly convoluted with loosely arranged thin layer of
stroma. Uterine glands were rarely found (Figure 14).
4.3 Scanning Electron Microscopic Observations of the
Control Mouse Placenta and the Uterine Epithelial
Surface during the Estrous Cycle
4.3.1 The Mouse Placenta
Under scanning electron microscope, similar structures
were found in the control mice placentae from the 1st
to the 7th day after saline injection. Greater details
of the trophoblasts were revealed (Figures 15, 16) 1.7).
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The labyrinth was composed of maternal and fetal blood
spaces separated by the trophoblasts (Figure 15). The
trophoblastic septa was made up of cytotrophoblastic
cells. The trophoblastic lamellae were arranged into
three layers. Layer I enclosed the maternal blood spaces
and had direct contact with maternal erythrocytes. This
layer was loosely applied onto the next layer. Layer II
was probably the thickest layer, which was very closely
adhered to layer III. Beyond this, a loose sheet of
fetal endothelium was found which encloses the fetal
blood spaces (Figures 16, 17). There were also numerous
fenestrations present within the layers and among them.
The nucleated fetal blood cells were larger in diameter
than the maternal enucleated erythrocytes (Figures 15,
16, 17).
The spongy zone was a rather homogenous sheet of
irregular shaped spongioblasts. These spongioblasts were
packed together with some protrusions so that there were
some intercellular bridges between the cells (Figure 18).
4.3.2 The Mouse Uterine Epithelial Surface
Under the scanning electron microscope, the charac-
teristics of the uterine epithelial cell surface during
the estrus cycle were observed.
.At proestrus, the uterine epithelium consisted of
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cells of uniform size with evenly distributed short
microvilli. Sometimes leucocytes could be found at the
lumen (Figures 19, 20, 21).
At estrus, the uterine epithelium was more or less
similar to that at proestrus. Deep folds of the uterine
lumen were found. Dense short microvilli covered uterine
epithelial cells were observed. Moreover, uterine
glandular openings were prominent and small secretory
granule was found on the cell surface. It suggested a
burst of secretory activity at this phase (Figures 22,
23).
At metestrus, the uterine epithelium appeared to be
degenerating. The cell size varied considerably as some
cells became swollen. Some cell surfaces were partially
denuded of microvilli (Figure 24).
At diestrus, the uterine epithelial cells showed
that the cells had predominantly short, stubby microvilli
covering their surfaces, but occasionally longer
microvilli could be found (Figure 25).
On the other hand, the uterine surface just after
parturition was shown to be different from the normal
uterine surface at the diestrus phase. The epithelial
surfaces were covered with short irregular microvilli
with some mucus-like substances coated on them to make
the microvilli glue together. Secretory productions were
prominent (Figure 26).
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4.4 Light Microscopic Observations of the Mouse Placenta
Treated with o-Momorcharin and the Recovery of the
Treated Mouse Uterus after the Induced Termination of
Pregnancy.
Since the major histological changes of the placenta
were various types of villous lesions, so when examining
the villi histologically attention had to be made to the
syncytiotrophoblast, the cytotrophoblast, the villous
stroma and fetal-capillaries (Fox, 1975). In my
experiment, the observations were mainly focused on the
villous portion of the placenta.
After the mice were treated with oc-momorcharin at a
dose of 0.2mg/25g body weight, the sequential damage of
the placenta was observed. It showed that the degree of
each placenta was different but the damage of the
placenta was' greater: -as-- time went by.
On the first day after drug injection, sign of
damage was found at the basal zone of the placenta.
Nuclear pyknosis was found in the trophoblasts and
sometimes even in the giant cells. Intercellular spaces-
were enlarged while fetal blood spaces were regressed and
maternal blood spaces were occluded. The
cytotrophoblasts became shrunken and stained more
basophilic. Moreover, the blood spaces filled with
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masses of cell debris. The cell debris included the
clotted blood cells, extruded pyknotic nuclei, cellular
fragments, detaching trophoblastic cells and a network of
fibrin (Figure 27). Simultaneously, the maternal blood
vessels in the decidua-basalis were filled with
aggregations of leucocytes. Some nuclei of the decidual
cells underwent pyknosis (Figure 28). However, the
myometrium seemed not to be damaged on this day.
On the third day after the drug treatment, the
overall condition intensified with frequent blood clots
and extensive nuclear pyknosis. The labyrinth was
highly disorganized with prominent vacuolated spaces and
detaching trophoblasts. Thickening of trophoblasts was
found with much cell fragments which seemed to be
decaying tissue. Leucocytes and network of fibrin could
be observed in the blood spaces (Figure 29). Moreover,
aggregation of leucocytes in the clotted decidual vessels
were markedly increased, whereas pyknotic nuclei and
detached cell fragments were obvious in the decidua
(Figure 30).
As the time of treatment prolonged to the 5th day
after the drug administration, the placenta became more
and more disorganized. The' sequential changes were
continuous and the destruction was more advanced. The*
whole layer of cells in the basal zone had turned into
masses.of structureless tissues and cell debris with
clotted blood cells were apparent. The basal zone was
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completely annihilated (Figure 31).
On the 7th day after the treatment, highly
disorganized placental structures were observed. It
showed that the labyrinth was completely wiped out as
dissolution of tissue could be found at this area. In
the decaying placental tissue, cell structure was hard to
be recognized among the cell debris but some nuclei could
be found detaching into the blood space (Figure 32). At
the same time, some placentae had already dislodged from
the maternal uterus so that recovered uterus could also
be observed. The uterus at this time was at'proestrus
which contained a much convoluted epithelial layer.
However, the mucosa in the endometrium was very thin and
uterine glands were difficult to be observed in the
uterus but detached and decaying placenta still remained
in the uterine lumen (Figure 33). The smooth muscle cell
had reduced its cell size as it was hypertrophied at the
gestation period. Blood clots were prominent in this
layer (Figure 34). Sign of the cyclic changes of the
uterus-recovered now as it was at the diestrous phase
before this day.
On the 9th day after x-momorcharin injection, the
placenta, if present, remained in masses of cell debris.
Highly vacuolated basal zone with blood clots and cell
debris was observed in the decaying placenta (Figure 35).
The uterus at this time was at diestrus and leucocytes
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were prominent in the thin layer of stroma (Figure 36).
When the mice were sacrificed later on the 11th day and
onwards from this day, the uteri of the treated mice were
recovered and cyclic changes of the uteri could be
observed from both the histological structure of the
uterus and the'vaginal smear. However, some blood clots
were shown at the region between the stroma and the
muscle layer on the 11th day after drug injection (Figure
37). On the 13th day, large 'decaying tissue which may be
the detached structureless placenta found in the lumen.
In the thin layer of stroma, glandular secretions were
obvious (Figure 38).
As the mouse was sacrificed on the 15th day after
the treatment, its uterus was at estrous phase. However,
distension of the stroma was not shown in the uterus and
the f oldings, at the, outer layer of the myometrium were
still observed (Figure 39). On the 17th day after the
administration, prominent leucocytes were obvious in the
thin layer of stroma. The myometrium was found to heal
at this time as no foldings were found in the outer
muscle layer and the muscle cells regained its normal
size and few collagen fibers could be found (Figure 40).
From the 19th to 23rd day, no obvious changes were found'
except that the stroma was still thin and not to be
distended even at proestrus or estrus (Figures 41, 42,
43). On the 25th day, the uterus was believed to be
entirely recovered as no obvious changes were found by
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light microscopic observation (Figure 44).
4.5 Scanning Electron Microscopic Observations of the
Mouse Placental Labyrinth Treated with X-Momorcharin
and the Recovered Uterine Epithelial Surface after
the Termination of- Pregnancy
According to Fox's opinion (1975), the histological
changes of placental lesions were mainly found on the
syncytiotrophoblast, the cytotrophoblast and the villous
stroma, observations using scanning electron
microscopy in this experiment would also be focused on the
villous lesions.
On the first day after the drug treatment, the
trophoblasts in the labyrinth were thickened and
regressed fetal blood spaces were observed (Figure'45).
The maternal blood.spaces were occluded by blood clots
formed by erythrocytes with detached trophoblastic cell
debris (Figure 46). Due to the thickening of the
secondary trophoblasts, the trophoblastic lamellae were
shortened and became more fragile. Parts of the lamellae
were fragmented and detached. The trophoblasts around
the blood spaces were disintegrated and crumbled so that,
the normal arrangements into layerings and the
fenestrations were destroyed. The general impression of
the labyrinth was its loosening up. Even the fetal
endothelium was eroded and the blood cells were damaged
with deformed plasma membrane (Figures 47, 48).
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Leucocytes and reticulum of fibrin appeared in the
maternal space (Figure 49).
On the third day, extensive aggregation of
leucocytes were. found with networks of fibrin and
disintegration of trophoblasts (Figures 50, 51). Damaged
and fragmented trophoblastic lamella detached into the
blood spaces (Figures 52, 53). On the fifth day after a-
momorcharin treatment, highly disorganized placental
structure appeared to tear off from the uterus (Figure
54). Trophoblastic fragments were found frequently in the
structureless mass of placental tissue (Figure 55).
Decaying tissue with masses of debris which included
detached cell fragments with deformed plasma membrane was
found to clump together in the blood space at this time
(Figure 56).
On the seventh day after the injection, the
placental cone appeared to dislodge from the uterus
(Figure 57). This placenta was highly disorganized as
occluded maternal blood spaces with condensed
trophoblastic cells and cell debris were obvious (Figure
58). Recovered uterine surface could also be observed.
The phase-of the estrous cycle at this time was different
from that at pregnancy which was at diestrus but the
recovered uterus on this day was at proestrus as shown by
the short microvilli on rounded apical uterine surface
(Figure 59). However, some apical cell surface showed
few or no microvilli so that it was postulated that the
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uterus was not completely recovered (Figure 60).
On the ninth day after drug treatment, the
degenerating placenta was found to have masses of tissues
containing detached cell fragments, leucocytes and other
cell debris (Figures 61, 62). The uterus at this time
was at diestrus but their rounded apical surface is only
covered with short microvilli (Figure 63). No long
microvilli were shown on the epithelial surface.
Detached decaying placenta still remained in the lumen
when dissecting the uterine horn open.
From the 11th day to 19th day after a-momorcharin
administration, the uteri appeared to gradually recover
to normal condition except some decaying materials, cell
debris or membrane protrusions might be found in the
lumen or on the cell surface. On the 11th day, some
debris on the apical surface were believed to be detached
fragments from the degenerated placenta as these debris
were not found frequently on the control uterine surface.
Besides, the short microvilli only sparsely covered the
cell surfaces (Figures 64, 65). On the 13th day, damaged
apical cell surfaces of the treated mouse uterus at
metestrus were apparent (Figure 66). No prominent
changes were shown at low magnification on the mouse
uterus on the 15th day after the treatment (Figure 67).
At higher magnification, some small spherical membrane
protrusions could be precisely characterized at the
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apical surface (Figure 68). On the 1/tn aay arter
administration of c-momorcharin, the uterus was at
diestrus and the apical cell surfaces were covered with
short microvilli. But long microvilli were also abundant
though these long microvilli were only occasionally
occurred in the control. Cell debris might be present
(Figure 69).
From the-19th day onwards to 25th day, the uteri
appeared to have completely recovered to normal structure
since no apparent changes were observed on the uterine
cell surfaces during this period (Figures 70, 71, 72,
73)_
4.6 Changes of Chorionic Gonadotropin Level in the Mouse
Placenta Treated with X-Momorcharin
Mouse chorionic gonadotropin (CG) content could be
detected in all pools of placentae on every alternate day
from the first to .seventh day after the drug
administration.
The time profile of chcrionic gonadotropin content
after the injection was shown in the graph (Figure 74).
The CG content in the control group rose after the day of
drug administration (i.e. PD-10, the CG level was
0.05±0.003ng/placenta) and attained a maximum level one
day--- later (CG level was 0.067±0.004ng/placenta), after
which a fall in CG concentration occurred. However,.. in
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the treated group, the CG content remained in a low level
(CG content of the treated group: from the 1st day to the
7th day, its value remained around 0.04ng/placenta).
Significant difference in CG level occurred on the
first and third day after drug treatment (pO.05). Since
it was the time that the trophoblasts were in their
actively proliferating and secretory phase, if any
destruction of trophoblasts occurred, the subsequent CC
changes would be prominent. It was also found that the
latter the animals were sacrificed, the smaller the
difference in CG levels was observed, and thus there was
no significant difference between the control and treated
group- on the 5th and 7th day after a-momorcharin
injection. It was probably because the drug had been
metabolized by the body so that the CG remained in a
constant level while it also dropped to a low level in
the control group as the result doneby Wide and Wide
(1979).
4.7 The Contractile Response of the Isolated Uterus from
the Druz Treated Mouse to Oxtocin
In this experiment, oxytocin produced a dose-
dependent contraction in the' longitudinal muscle of the
mouse myometrium. Figure 75 showed, an original tracing
of the contraction of a strip of muscle to increasing
concentrations of oxytocin. The range of oxytocin was
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about 5 x 10-5 U/ml to 5 x 10-1 U/ml. The averaged dose-
response curves for the control and O-momorcharin
treated group were shown in`a series of figures (Figures
76, 77, 78, 79, 80, 81, 82, 83). In the control groups,
the maximum response ranged from 1.00g to 1.222g and that
of the treated. group from 0.57g to 1.10g.
When comparing samples of the uteri obtained from
the control and-the treated mice on every alternate day
from the 11th to 25th day after O(-MMC or saline
infusion, two parameters, the maximum tension (Emax) and
the ED50 were calculated from each dose response curves
for statistical. analsis.
In the samples taken from the first two days (11th
and 13th day) there was highly significant decrease
(p0.01) in Emax in the treated group (Figures 76, 77).
In the samples of the following 4 days t 15 h,
17th, 19th and 21st day), significant reduction (p0.05)
in the Emax was found in the treated group when compared
to the control except on day 1:9 in which the difference
was not significant (Figures 78, 79, 80, 81). In the
last-two days.(23rd.and 25th day), there was no
significant.difference (p0.05) between the Emax of both
groups.(Figures 82, 83).
Although the Emax in treated group showed a
significant decrease during initial periods after drug
administration, there were no significant differences in
59
the ED50 measured in the whole time course studied. From
the data (Figures 76, 77, 78, 79, 80, 81, 82, 83) it was
clear that there was no difference in ED50 of all the
curves compared although a trend of slight increase in
ED50 can be seen in some treated samples.
4.8-Second Pregnancy Test of the D(-Momorcharin Treated
Mouse
After the 10th day pregnant mice were
administered with o(-momorcharin at a dosage of 0.2mg/25g
body weight, second pregnancy test was done on the
following day after the drug treatment. It was found
that there was no significant difference on the day of
second mating (i.e. the day that second pregnancy
occurred) between the control and treated group (for the
treated group (n=4).,'the day for second pregnancy was on
23.8+1.7 days after the drug injection while for the
control (n=8), the second pregnancy occurred on 22.9+1.0
days after saline injection). In addition, the day for
the second parturition (i.e. 17.8+0.8 days of the second
pregnancy for the treated and 18.4±0.3 days for the
control) and the number of fetuses at the second
pregnancy (i.e. 8.0+1.82 for the treated and 8.8+0.9 for
the control) also showed no significant difference
between the control and treated mice (Table 2).
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5. DISCUSSION
5.1 Gross Changes of the Drug Treated Mouse
From the gross changes in the treated mouse, the degree of
damage in each placenta is different. It may be postulated that a`
-momorcharin acts in the various placentae'of the same mouse at
a different.rate. In addition, reduction in body weight after
the drug administration may be a cumulative effect of
cytotoxicity and partial resorption of the fetuses and
placental residues. As Ot-momorcharin causes resorption of the
placenta.in the mice, it is probably not a uterine stimulant
for termination of pregnancy (Lau, 1983; Law,1983). However,
detailed mechanism of the x-momorcharin in triggering
resorption of the placenta awaits further investigation. As it
is found that there is no apparent relationship between fetal
or placental weight and average distance from the neighbouring
implantation at gestation (Rahima and Bruce, 1986), the
decrease in placental weight is believed to be the result of
the placental damage but not due to the local crowding of
fetuses and placentae'in the uterine horns which may be thought
to make the average placental weight decrease.
5.2 Histological and Hormonal Changes of the -MMC Treated
Mouse
From the histological observations, it shows that Ck-
momorcharin causes extensive damage in the basal zone.
In the basal zone, the primary site of action is believed
to be the trophoblasts since nuclear pyknosis is first
seen in the response for the tissue to the drug. The drug
may get into the trophoblastic cells by diffusion or
61
by receptor transport and causes metabolic disorder by
blocking some essential pathways of metabolism and
eventually the cells die. Since this close association
in the labyrinth infarcts to obstruct. all the diffusion
mechanisms, normal transport system will be impaired.
This will lead to depletion of oxygen and nutrients of
the fetus, or an accumulation of waste products. This-..
situation of anoxia, will hinder the fetal development.
Besides, X-momorcharin has also been found to show
cellular damage in the embryonic ectoderm in treated
embryos during early pregnancy (Law et al., 1983 Tam. et
al., 1984) therefore the drug may also act on the fetus
and finally lead to fetal death. In addition, as the
maternal blood supply is deficient, the trophoblasts
which are entirely dependent on this blood supply will
undergo ischaemic, degenerative and necrotic changes
(Robertson and Dixon, 1980). Moreover, the fenestrations
on the trophoblasts are lost. and consequently molecules
transport across the fetal maternal barrier is impaired
or meets with much higher resistance. As a result, with
a decrease in blood flow-and an impaired transport
apparatus, the nutrient supply from the maternal
circulation to the fetus as well as the placental tissues
is decreased.
The placenta can be regarded as an.endocrine organ,
secreting hormones in support for gestation (Petropoulos,
1973). When the concentration of the hormones changes,
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normal pregnancy will be terminated. Therefore, changes
in hormonal level will lead to abortion. Termination of
pregnancy can also be brought about by hormonal imbalance
due to tissue damage caused directly by drug action or
indirectly by depleted nutrient supply. Since the
trophoblasts may indirectly secrete hormones for
maintaining pregnancy (Midgley and Pierce, 1962), the
damage to these tissues by drugs may result in hormonal
imbalance and subsequently termination of pregnancy
(Pattillo and Hussa, 1984). In this experiment, as the
drug can destroy the normal synthetic activities in the
trophoblast, hormonal production is thus arrested.
Throughout pregnancy in the mouse, maximal amount of
chorionic gonadotropin is found on day 11 of gestation as
it is the period that trophoblasts are at their active
proliferation (Wide and Wide, 1979). Therefore,
significant difference in the chorionic gonadotropin
level between the control and treated group is found on
this day in the present experiment. The fall in
chorionic gonadotropin level in the drug treated mouse
placenta at this time may then indicate a decreased
placental function due to the death of the hormone
producing cells, the trophoblast. Subsequently it
impairs steroid hormone production such as progesterone
which can maintain pregnancy (Rice et al., 1964), and
thus, an indication of termination of pregnancy occurs.
Therefore, from the histological observations, it seems
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more probable that the fall of the chorionic gonadotropin
is of secondary cause than a primary cause of the
abortion, i.e. the destruction of the trophoblastic cells
appears first, then comes to the decrease in the
chorionic gonadotropin level which finally causes the
impaired steroid hormone production, and finally
termination of pregnancy occurs. It is also found that
when the treatment is- prolonged,:- the differences in chorionic
gonadotropin content become smaller. It may be
postulated that the drug is metabolized omit may also
signify continued production of chorionic gonadotropin
from functioning trophoblastic tissue for a period of
time after abortion (Steier et al., 1984). As the drug
is metabolized in the mouse, the placental damage during
this period (i.e. from the 5th to the 9th day after the
drug treatment) may be due to internal degeneration of
the tissue. Moreover, as an increase of chorionic
gonadotropin signifies an increase in tissue mass,
whereas decreased value indicates a reduced placental
mass or abnormal trophoblastic function (Braunstein,
1978. K.lopper, 1980), the decrease in placental weight
may be a result of the decrease in the hormone production
after the drug treatment.
In prolonged treatment,' the placenta becomes a mass
of structureless tissue and begins to detach from the
uterus. The detached placenta is reabsorbed and decayed
gradually. It is found that extensive accumulation of
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cell debris resulting from fragmentation of dead. cells.
Pyknotic nuclei are extruded by a process called
karyorrhexis, and is followed by dissolution of the cell
fragments. As these materials are extruded continuously,
they clump together in the maternal blood spaces, and
thus the blood spaces are occluded. Erythrocytes in the
blood stream are caught in the mass of debris and with
the formation of a fibrin network, blood clots are
formed. In addition to causing nuclear•pyknosis, the
drug has also shown to cause trophoblastic.thickening,
vacuolation and loosening. As a result, thickened,
shortened or stretched trophoblastic lamella is formed
that will destruct any transport mechanisms (Lau, 1983
Ooi et al., 1986). Therefore, fetal death is resulted as
the nutrient supply is blocked. Moreover, the
accumulation of cell debris from trophoblastic necrosis
and decidual cell fragments will activate.:.an acute
inflammatory response of the mouse. Aggregation of
leucocytes is obvious at this time that may be important
for the lysis of the detached and damaged cells in the
placenta. Blood vessel-walls increase permeability and
eventually leads to rupture and lesions. In addition,
blood clots in the vessels tend to narrow down the lumen
of the vessels-and so increase..: the blood pressure. As
a result, red blood cells may leak out forming,a
hemorrhage. Moreover, the drug, o-momorcharin, being a
high molecular weight protein, may act as an antigen and
trigger the immune response of the mouse. Leucocytes may
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also be responsible for the resorption of dead fetuses
and placental tissue. Due to a-general obstruction in
the placental circulation,. the waste materials are not
easily removed away or metabolized. It leads only to
partial resorption while the rest undergoes internal
degeneration in the uterine lumen. From various studies
on the histopathological changes in the placenta and on
the functional competency of trophoblast cells which is
indicated by chorionic gonadotropin production,
trichosanthin always preferentially affects the
syncytiotrophoblasts in the placenta (Tso et al., 1976
Wang et al., 1976). oC-momorcharin also shows similar
cellular lesion of the trophoblastic cells and a
decrease in the chorionic gonadotropin content. Hence, D
-momorcharin seems to act on the trophoblastic cells and
thus impair the hormone secretion. This resultant
placental deficiency caused by localized tissue
infarction' and ischaemia, the failure of the transport
system and the defective hormonal production may result
in fetal death and termination of pregnancy.
After the placentae of the treated mouse have
completely dislodged from the uterine horns, the uteri
seem to be recovered gradually as observed by light
microscopy. On the 7th day after the treatment of X-
momorcharin, the smooth muscle cells begin to reduce its
size and the amount of collagenous connective tissue also
decreases. It may be due to the supportive function by
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the hypertrophied smooth muscle cells and the collagenous
connective tissue in the thickened myometrium is no
longer needed as the placenta has already dislodged from
the uterus. It is believed that the uterus has undergone
involution similar to that happened in the mouse uterus
after parturition (Afting et al., 1979 Shimizu et al.,
1985). It may be postulated that autophagocytosis has
occurred so that the size of smooth muscle has reduced.
But it is not the major mechanism responsible for the
size reduction of the cells (Henell et al., 1983).
Heterophagocytosis of smooth muscle cells by leucocytes
found in the clotted blood spaces on the 7th day after
treatment may be also possible to have the ability to
endocytose cytoplasm and all debris including split off
bits of smooth muscle cell cytoplasm. Moreover, the
collagenous connective tissue is resorbed because fewer
amount of the fibres is observed in the myometrium from
the 7th day onwards. Therefore, the collagen may be
degraded by heterophagy or even by crinophagy though
fibroblasts are not observed (Parakkal, 1969; Shimizu et
al:,,1983 Shimizu and Maekawa, 1983). From 7th day
after the treatment onwards, the uterus seems to be
recovered except debris from the decaying placenta still
remains in the uterine lumen from the 7th to the 13th
day. Besides, the uterus of this period and that on one
day after parturition shows similar appearance, i.e. the
stroma is very thin and few uterine glands are found in
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the stroma. It is probable that uterine repair requires
these tissue to act as stem cell population for the
renewal of the surface epithelium (Finn, 1975; Leroy et
al., 1981). Therefore, the effect of m-momorcharin is
different from that of its analog protein B-momorcharin
since the latter one will cause a greatly thickening of
endometrium with elaborate uterine glands and diminishing
cell proliferation in Lhe endometrium and myoretrium
(Chan et al., 1984a Tam et al., 1985). Since the uterus
begins to involute, recovery of the uterus'to its normal
size will be completed within three days after delivery
as it is found that the weight and collagen content of
the uterus shows a rapid decrease during the first 3
postpartum days in normal mouse (Shimizu et al., 1983
Shimizu and Maekawa, 1983 Shimizu et al., 1985).
It has been shown that in the normal mouse 3 days after
postpartum, collagenase appears and is maintained at
high levels throughout uterine involution (Jeffrey et al,
1971). However, the uterus in the treated mice needs a
longer time for the uterine involution. It is probable
that the decaying tissue still remains in the uterine
lumen or the collagenase production is very low.
[fence, further investigations should aim to detect the
synthesis of collagenase after treatment of x-momorcharin
so as to ensure when uterine involution happens after
termination of pregnancy. From the 19th day onwards, the
myometrium of the uterus is believed to be completely
recovered since the folding of the myometrium is not
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observed and no obvious changes are found on this day.
However, from the 9th to 23rd day after drug injection,
the stroma in the treated mouse is still very thin though
the uterine glands and the muscle layers are recovered.
On the 25th day after treatment, the uterus is entirely
recovered as distention of the stroma is also observed.
However, scanning electron microscopic observations
have demonstrated that there are cell debris in the
uterine lumen on the 7th, 9th, 11th day after the
administration' of a-momorcharin. In addition, damaged
cell surfaces are prominent on the 13th day and it is
similar to that reported in the hamster endometrial cell
surfaces exposed to diethylstilbestrol (Gilloteaux and
Steggles, 1986). It may indicate that the uteri in these
treated mice are not comple-tely recovered as cell debris
which may be the decaying placental tissue remains in
the uterine lumen. The cell debris and the damaged
uterine surface will affect blastocyst implantation for
the second pregnancy. The uterine cell surfaces are
found to be different from that in the control mouse one
day after parturition. No secretory products are
observed in the uterine lumen in the treated mouse. This
may be due to the endometrial mucosa in the treated mouse
does not need any mucus secretion to lubricate the
uterine surface for delivery after induced-termination of
pregnancy. Moreover, as observed by light microscopy,
the uterine glands are not recovered and well-developed
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after drug administration for 11 days, so no secretory
product is found. The spherical membrane protrusions
on the uterine surface observed on the 15th day after the
drug treatment are similar to those found in rat treated
with progesterone (Nilsson, 1972 Parr and Parr, 1974
Craig and Jollie, 1984) Therefore, these protrusions
found on the epithelial cells in the treated mouse uterus
may facilitate the process of endocytosis of the
cytoplasm (Parr and Parr, 1974) or cell debris split off
from the damaged cell in the uterus and thus enhance the
recovery of the uterus sooner.
On the 17th day after treatment of x-momorcharin,
prominent long and short microvilli are found on the
uterine apical surface. Though these long microvilli can
also be found at diestrus in the normal mouse uterus, the
occurrence is very rare. In the treated mouse uterine
surface, prominent long microvilli will increase the
uterine cell surface to augment absorption by the
epithelium, or transport of electrolytes for metabolism
(Anderson et al., 1975). Hence, it may be suggested that
during the uterus undergoes the recovery process these
long microvilli are necessary for the absorption or
transport of nutrients for metabolism and healing of the
uterus. From the 19th day onwards, the uterine cell
surfaces are shown to be completely recovered as no
apparent changes are observed. The recovery of the
uterus may be due to the increase in removal of cell
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debris in the lumen and metabolic rate for repair of the
damage of the uterus. However, the recovery of the
uterus after drug treatment is delayed as compared to the
control, in which involution takes about 3 days after
postpartum (Shimizu et al., 1983a, b; Shimizu and
Maekawa, 1983). It indicates that X-momorcharin may
somehow affect the biochemical or physiological
mechanisms involved in the recovery of the uterus.
Therefore, the rate of cellular proliferation is reduced
and the stromal, epithelial and glandular cells
differentiated poorly and slowly, and thus a delayed
recovery of the uterus is resulted.
5.3 Contratility of the Recovered Uterus of the Treated Mouse
From the results of the present investigations, it
is known that p-momorcharin only triggers resorption
rather than expulsion of the placenta after the drug
treatment. It is probable that the drug is not able to
stimulate oxytocin or oxytocin receptor production for
uterine contraction during termination of pregnancy. The
results of oxytocin-induced contraction of the uterine
smooth muscle after termination of pregnancy shows that
from the 11th to 21st day after cA-momorcharin injection
the response of the treated group is significantly
reduced, the effect being most prominent from day 11 to
day 13. From the 23rd day onwards, there is no
difference. In the control group, the Emax decreases
gradually and is lowest in the last day, i.e. the 25th
day after the drug administration. This is the expected
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result since it is known that uteri near parturition is
more sensitive to oxytocin (Fuchs, 1986; Riemer and
Roberts, 1986). On the contrary, the Emax of the treated
group has a trend to gradually increase from the 11th to
25th day. There are at least two explanations for the
present observations. Firstly, the contractile mechanism
of the uterine muscle may be impaired by structural
damage caused by the drug. Secondly, the uterine muscle
may not be damaged at all but-that the normal production
of oxytocin receptors near parturition is affected
because of the abortifacient effect of X-momorcharin.
In other words, the reduction in the maximum amount of
uterus contraction in the treated group may be a
secondary effect. Since histological studies reveal no
sign of myometrium damage, the second explanation is
considered to be more likely. It indicates that the
plasma membrane of the smooth muscle cell may be affected
by the drug since oxytocin receptors are located on the
plasma membrane of smooth muscle cells (Soloff et al.,
1975; Fuchs, 1986). The finding that the ED50s of all
dose-response curves between the control and treated
group do not differ significantly is consistent with the
notion that the number of oxytocin receptor is reduced
instead of the sensitivity of the muscle to oxytocin.
Hence the myometrial sensitivity to oxytocin which rises
sharply at the time of parturition is not altered by the
drug. Since from 23rd day onwards there is no difference
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in both the Emax and ED50 between the control and treated
group, the uterus is considered to have recovered, if
there has been any damage to it. At this time, it is
believed that the uterus of the treated mouse can support
second pregnancy. Moreover, radioimmunoassay can be
carried out to test if any oxytocin produced after the
administration of the drug so as to find if X-momorcharin
is a uterine contraction stimulating drug since
trichosanthin, which is-also a Chinese medicinal
abortifacient drug, can enhance the response of the
uterus to oxytocin and therefore stimulates uterine
contraction directly (Shu et al., 1979), although the
present data would suggest a negative result of such a
test. A different approach such as transmission electron
microscopic observations can be used to find out more
ultrastructural changes within the cell in the placenta
and uterine stromal, epithelial and myometrial cells of
the mouse after the treatment of c-momorcharin.
5.4 Second-Pregnancy Test
From the results of the second pregnancy test,
it indicates that c-momorcharin is not an accumulative
drug since the drug does not affect the ovary, uterus
or placenta of the mother mouse at the second pregnancy.
The test indicates no difference in the X-momorcharin
treated mice and normal mice, with respect to.day of
mating, duration of pregnancy and the number of off-
springs. However, when the.uterus of the treated mouse
has not entirely recovered to normal condition, the
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stroma is thin and cell proliferation is reduced which is
similar to the effect of X-momorcharin (Chan et al., 1984a,
b) and may inhibit decidualization, and the cell surfaces
may decrease cell adhesiveness for blastocyst implantation
or cannot promote sperm transport or capacitation of sperm
before fertilization as the luminal epithelium in normal
mouse can play a role in fertilization and implantation
(Nilsson, 1966; Corbeil et al., 1985). In addition, the
mouse ovary is not affected and ova can be produced so that
second pregnancy is obtained and the litter size is as that
in the normal (Bronson et al, 1968). It may be postulated
that the drug, after injected into the mother mouse, will be
metabolized and its cytotoxic effect will be faded gradually
after detoxification and clearance so that the uterus of the
mother mouse may recover entirely on the 25th day after
treatment of -momorcharin. The fetuses born seem to be
normal as observed,by its gross appearance. Hence, it can
be concluded that d-momorcharin is an effective
abortifacient drug for mid-term pregnant mouse which seems
preferentially to affect the trophoblastic cells and no
accumulative effect is shown in the treated mother mouse in
the second pregnancy.
5.5 Conslusion
However, further investigations should be continued
such as to study the pathway of drug absorption,
distribution, metabolism and excretion in the mother
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mouse and determine if side effects on renal function and
hepatic function occur in the mother mouse. Moreover,
the effective therapeutic dose and lethal dose should
also be thoroughly studied to increase the effectiveness
and safety of the drug. Finally, it is most important ,to
explore the drug potential in inducing termination of
mid-term pregnancy in human-beings after the exact
mechanisms of termination of pregnancy using this drug
are found-out and proved to be-therapeutically
satisfactory with no undesirable complications.
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TABLE 1. Comparison of the percentage of viable fetuses
in control (saline injected) and treated (X-MMC injected)
mice on day .1, 3, .5 and 7. N. represents sample size
for each group of data. Data are expressed as mean±SEM.
Figure 1. Comparison of the placental weight in control
(saline injected) and treated (c-MMC injected) mice after
injection on day 10. White blocks represent control data
and black blocks represent data from treated mice.
Included in the brackets are the number of samples and.
the S.E.M.of the means are represented by each small bar.
J p, 0.05- p 0.01)


























Figure 2. Cross section of the control mouse placenta
on the-eleventh day of pregnancy showing layering
structure. The outermost layer closest to the fetus is
the labyrinth (L) and next to it is the spongy zone (S)
and the giant cell layer (G). The inner most layer is
the decidua basalis (D) which is penetrated by maternal
vessels (arrow). The placenta is separated from the
myometrium (M) of the maternal uterus by a thin layer of
stroma (St) which is made up of connective tissues.
During parturition, the placenta will be detached at this
Doint. X50.
Figure 3. At higher magnification, the maternal biooa
spaces and fetal blood spaces are separated by the
trophoblasts. Maternal blood cells or erythrocytes (e)
are enucleated while fetal blood cells (f) have a central
nucleus and clear cytoplasm. The trophoblastic septa
(TS) is composed of basophilic cytotrophoblastic cells.
Mitotic figures are frequently seen in the trophoblastic
septa (arrow). The trophoblastic lamella (T) is
generated by the trophoblastic septa. It serves to
separate the maternal blood spaces from the fetal blood
spaces. The maternal blood space is devoid of an










Figure 4. The spongy zone (S) of the control mouse
placenta is composed of small, compact and basophilic
cytotrophoblastic cells called spongioblasts. Mitotic
figures (arrow) are frequent since it is believed that
the spongy. zone gives rise to the labyrinth and-the giant
cells (G). X500.
Figure 5. The giant cells (G) of the control mouse
placenta are spindle shape with a large central elongated
nucleus. Due to the large size, the nucleoli (n), the
euchromatin (e) and the heterochromatin (h) are readily








Figure 6. The decidua basalis of the control mouse
placenta is a very thick layer. It is composed of
compact, rounded cells (d) but with poorly defined cell
boundaries and polygonal stroma cells (s). X500.
Figure 7. The myometrium of the control mouse showing
bundles of connective tissue fibers (C) intervening among






Figure 8. Cross section of the control mouse uterus
at proestrus showing active mitosis in the epithelium (m)
and prominent blood vessels (b) and tubular glands (u) at
the stroma. The stroma (S) is distended so that the
uterine wall is quite thick. Leucocytes are hard to
observe in the stroma of the uterus. X250.
Figure 9. Cross section of the control mouse uterus
at estrus showing numerous mitotic figures (m)
indicating mitotic activity is maximum at this phase.
Distention of the uterine wall reaches maximum and so
leucocytes are hardly found. Uterine glands (U)




Figure 10. Control mouse uterus at metestrus showing
degenerated epithelium (d) and rare mitotic figures.
Uterine glands (u) are few and show minimum activity.
Distension of the stroma (S) decreases. X250.
Figure 11. Control mouse uterus at diestrus showing
regenerated epithelium with frequent mitotic figures (m).
Many leucocytes (arrow) are found in the stroma and









Figure 14. Control mouse uterus on one day after
parturition showing distended myometrium with much blood
places filled with clotted blood (c). Deep folds of
outer muscle layer (M) are formed. Prominent connective
tissues (C) are still obvious. X100.
Figure 15. Scanning electron micrograph of the
labyrinth of the control mouse placenta showing the
maternal blood spaces (M) separating from the fetal blood
spaces (F) by the trophoblastic lamella (L). The fetal
blood spaces are prominent. Fetal endometrium (arrow) is













Figure 16. Higher magnification of the control
mouse labyrinth showing maternal.blood spaces packed with
erythrocytes (E), and fetal blood spaces (F) containing
nucleated fetal blood cells. Cytotrophoblastic cells (C)
are elongated or spindle shaped germinal cells. The
trophoblastic lamella (L) is generated by the germinal
trophoblastic septa (S). The fetal endothelium (arrow)
is loosely applied on the trophoblasts. The maternal
blood space is devoid of an-endothelium but has-direct
contact with layer I of the trophoblast (arrow head).
X7800.
Figure 17. Scanning electron micrograph of the
labyrinth of control mouse placenta showing fetal blood
cells (F) in the fetal blood spaces which are bound by
the fetal endothelium (large arrow). The outer layer of
the trophoblastic lamella, layer I (arrow head) is
closest to the maternal blood space (E). It is loosely
applied to the lower layers. Layer II (T2) and layer III
(T3) are closely opposed and at places cannot be
separated. The layer closest to the fetal blood space is
the fetal endothelium. There are numerous fenestrations
(small arrow) in these layers. They are small
invaginated pinocytotic vesicles. Nucleus of the








Figure 18. Scanning electron micrograph of the spongy
zone of the mouse placenta showing a sheet of irregularly
shaped cytotrophoblastic*cells (C). Intercellular
communications (I) are found among them. X1980.
Figure 19. Scanning electron micrograph showing the
control mouse uterine surface at proestrus. The rounded







Figure 20. Higher magnification of a portion of
Figure 19. Rounded apical cell surfaces contain short
microvilli of a homogeneous length. X17,100.
Figure 21. Scanning electron micrograph showing some
leucocytes (L) in the uterine lumen of the control mouse




Figure 22. Scanning electron micrograph showing the
control mouse uterus at estrus. The epithelial cell
surfaces are rounded and contain short microvilli and
apparent grandular openings (arrow). Well-defined
uterine folds are prominent. X1800.
Figure 23. Scanning electron micrograph at high
magnification showing uterine surface at estrus.
Numerous short microvilli of approximately equal length





Figure 24. Scanning electron micrograph snowing Lne
control mouse uterus at metestrus. It shows that the
uterine epithelium is disrupted with swollen cells (s)
and areas denuded of microvilli (large arrow). Some cell
surfaces with few microvilli (small arrow). Epithelial
cells are degenerative (d) with cell protrusions visible.
X6000.
Figure 25. Scanning electron micrograph showing the
uterine epithelial surface at diestrus. Smooth
epithelial- cells have less numerous short stubby







Figure 26. Scanning electron micrograph of the
uterine surface of control mouse one day after
parturition. The uterus is at the diestrus phase. The
epithelial surface is covered with short irregular
microvilli with some mucus-like substance coated on them
so that some microvilli seemed to be glued together.
Secretions (S) are also prominent. X10,800.
Figure 27. Basal zone of the mouse placenta after one
day treatment showing pyknotic nuclei (arrow), blood
clotting (c), reticulum of fibrin (r) and cell fragments
(f) detaching-in the blood spaces. The





Figure 28. Mouse placenta after one day treatment
showing leucocytes aggregation (L) and blood clots (c) in
the decidual vessels.- Sometimes nuclear pyknosis is
observed (arrow). X250.
Figure 29. Mouse placenta after 3 days treatment of a
-momorcharin showing extensive blood clots (c) and
nuclear pyknosis (p). Damaged and detached trophoblast





Figure 30. The decidua of the control mouse placenta
after three days of drug injection showing extensive
blood clots (c) with aggregations of leucocytes (L),
pyknotic nuclei (n) and detached cell fragments (d).
X500.
Figure 31. Mouse placenta after 5 days treatment
showing vacuolated spaces between trophoblasts (v),
frequent blood clots (arrow), aggregation of leucocytes
trapped in network of fibrin (L), detached pyknotic
nuclei (d) and cell debris (C). The placenta became




Figure 32. Mouse placenta after 7 days treatment of
the drug showing the decaying cell fragments. Occluded
blood spaces (o) are prominent with cell debris (D)
formed by lysis of cells. The placenta became a
etrit-11P1 P_ss mass of tissues. X500.
Figure 33. Cross section of mouse uterus after/ days
treatment of a-momorcharin showing a mass of decaying
tissue (d) in the lumen. The uterus is at proestrus. It
consists of the endometrium (E) with many crypts but no





Figure 34. At higher magnification, the myometrium of
the mouse uterus showing smooth muscle cells (M) reduced
in size and containing occluded blood spaces (o) with
pyknotic nuclei (N) and leucocytes (L). X500.
Figure 35. Mouse placenta after 9 days treatment
showing prominent vacuolated areas filled with blood
clots (c), frequent pyknotic nuclei (p), cell debris (d)




Figure 36. Mouse uterus on the 9th day after drug
treatment which is at diestrus showing leucocytes (arrow)
in the thin layer of stroma. X250.
Figure 37. Mouse uterus at estrus after 11 days
treatment showing numerous mitotic figures (M) in the
endometrium but the stroma (S) is thin and seems to be
collapsed. Blood clots (c) can be found at the region




Figure 38. Mouse uterus after 13 days treatment is at
metestrus. Stroma (S) is thin. Secretions (c) from the
uterine glands are apparent. Large decaying tissue (D)
which may be the detached placenta is observed in the
uterine lumen. X250.
Figure 39. Mouse uterus on the 15th day after the drug
injection which is at the estrus phase showing no mitotic
figures or uterine glands. The stroma layer (S) is thin.




Figure-40. Mouse uterus on the 17th day after drug
injection which is at diestrus showing mitotic figures
(m) in the epithelium and leucocytes (arrow) in the
stroma. The myometrium (M) seems.to have involuted as no
foldings are formed. X250.
Figure 41. Mouse uterus on the 19th day after
treatment which is at estrus showing prominent uterine
glands (u) but few mitotic figures. The stroma (S) is
not.distended but the myometrium (M) seems to have




Figure 42. Mouse uterus on the 21st day after drug
injection which is at metestrus showing degenerated
epithelium (e) and a thin.,layer of stroma (S). No other
apparent changes can be found. X250.
Figure 43. Mouse uterus on the 23rd day after the
treatment which is at proestrus showing numerous-uterine





Figure 44. Cross section of mouse uterus after 25
days treatment showing uterine gland (U) and mitotic
figures (m) in the distended stroma and epithelium at
proestrus phase. X250.
Figure 45. Scanning .electron micrograph of the mouse
placental labyrinth after one day treatment of DC-
momorcharin showing thickened trophoblasts (T) and











Figure 46. Scanning electron micrograph OL Lilt-- 111VUOV--
labyrinth after one day treatment showing an occluded
maternal blood space (m) filled with erythrocytes and
detached cell fragments (d), separated from a fetal blood
space (f) filled with fetal blood cells. Condensed
troPhoblasts (T) is shown. Trophoblastic lamella (L).
X5720.
Figure 47. Scanning electron micrograph of the mouse
labyrinth after one day administration of C-momorcharin
showing damaged fetal blood cell with deformed plasma
membrane (F) trapped within strands of fibrin (arrow) and
other cell fragments (f). Damaged trophoblasts (T),
disorganized trophoblastic lamella (L), detached cell
fragments and erythrocytes with deformed plasma membrane







Figure 48. Scanning electron micrograph of the mouse
labyrinth after one day treatment of a-rnomorcharin
showing fetal blood cells with deformed plasma membrane
(F) and detached cell fragments (D) in the blood space.
X8200.
Figure 49. Scanning electron micrograph showing a
maternal blood space (S) with reticulum of fibrin..(arrow)
and leucocytes (le) entangling the erythrocytes (e) after










Figure 50. Scanning electron micrograph of mouse
labyrinth after three days treatment showing blood spaces
filled with detached trophoblastic cells (D) and cell
fragments (f). Trophoblastic septa.(T). X6000.
Figure 51. Scanning electron micrograph showing
highly disorganized and fragmented trophoblastic..lamella
(TL) and cell debris (D) in the blood space. Leucocytes











Figure 52. Scanning electron micrograph showing
occluded maternal blood spaces (0) filled with
erythrocytes, detached cell fragments (f) and leucocytes
(L) after three days treatment of'c-momorcharin. X4000.
Figure 53. Scanning electron micrograph showing occluded
maternal blood space with red blood cells (E) trapped in
strands of fibrin (arrow) and many leucocytes (L) are
observed after three days treatment. Regressed blood










Figure 54. Scanning electron micrograph of the mouse
placenta after five days treatment of the drug. The
placenta (P) appears to dislodge from the maternal
uterus. Extensive blood clots are evident (B). X1800.
Figure 55. Scanning electron micrograph showing the
highly-disorganized placenta after five days treatment.
Cell debris (d) is prominent with networks of fibrin (f)







Figure 56. Scanning electron micrograph showing the
highly damaged mouse placenta after 5 days treatment.
Detached cell fragments (D) show deformed plasma
membranes. These cell fragments are clumped together in
the blood space. X6600.
Figure 57. Scanning electron micrograph of the mouse
placenta after seventh days treatment of 0(-momorcharin.
The placental cone (P.) appears to begin to dislodge from








Figure 58 Scanning electron micrograph of the mouse
placenta after seventh days treatment showing occluded
maternal blood spaces (0) with condensed trophoblastic
cells (t). Detached cell fragments and cell debris (DC)
are also obvious. X3000.
Figure 59. Scanning electron micrograph of the
treated mouse uterine surface on the seventh day after
the drug injection. The uterus is at proestrus phase.
Debris (D) that may come from the detached placenta is
observed and some leucocytes (L) are found at the uterine













Figure 60. Scanning electron micrograph of the
uterine cell surface on-the seventh day after the
treatment. The apical cell surfaces at proestrus have
short microvilli but some with few microvilli or denuded
(arrow). X10,800.
Figure 61. Scanning electron micrograph of mouse
placenta after nine days treatment showing damaged cell




Figure 62. Scanning electron micrograph showing
placenta after nine days treatment. Cell debris
including detaching cells (d), trophoblastic fragments
(t), damaged red blood cells (e)•and leucocytes (L) are
clumped together. X6000.
Figure 63. Scanning electron micrograph showing the
uterine epithelial surface at the diestrus phase on the
ninth day after a-momorcharin administration. No











Figure 64. Scanning electron micrograph of the mouse
treated for eleventh days showing the uterine epithelial
surface at estrus. The uterine mucosa with rounded,
uniform-size epithelial cells. Grandular openings
(arrow) and short microvilli are also present. Some
debris (d) can still be found on the apical surface which
may be the remaining fragments from the decayed placenta.
X1980.
Figure 65. Scanning electron micrograph of the mouse
uterine cell surfaces at estrus on the eleventh day after
the drug treatment. Sparsely distributed short





Figure 66. Scanning electron micrograph of the mouse
uterus at metestrus on the thirteenth day after the
treatment. Damaged epithelial cell surfaces (d) can be
seen. Other epithelial cells contain few, short
microvilli. X6000.
Figure 67. Scanning electron micrograph of the mouse
uterine surface at estrus on the fifteenth day after
administration of o(-momorcharin. Rounded apical cell





Figure 68. Scanning electron micrograph showing the
mouse uterine surface after fifteen days treatment.
Prominent short-microvilli covering cell surface with
some secretions are observed. Some small spherical_
protrusions (p) can be precisely characterized at this
higher magnification. X6600.
Figure 69. Scanning electron micrograph of the mouse
uterus at diestrus phase after seventeen days treatment
of c-momorcharin. The apical cell surfaces are covered
with prominent short and long microvilli (arrow). Cell





Figure 70. Scanning electron micrograph of the mouse
uterine epithelial surface at_ estrus after nineteen days
treatment of a-momorcharin. Apical cell surfaces are
covered with short microvilli. Glandular openings (g)
are also observed which show normal appearance. X4500.
Figure 71. Scanning electron micrograph of the mouse
uterus at metestrus after twenty-one days treatment of
the drug. The epithelial cells contain short microvilli
with disrupted swollen cells (s) and areas denuded of
microvilli (d). Some epithelial cells are degenerative









Figure 72. Scanning electron micrograph of the mouse
uterine apical surface at proestrus on the twenty-third
day after the drug treatment. The rounded epithelial
cell surfaces are covered with short microvilli of
approximately even length. X12,000.
Figure 73.' Scanning electron micrograph of the mouse
uterus at proestrus after twenty-five days of treatment.
Prominent short microvilli (arrow.) cover the apical





Figure 74. Comparison of the --CG content in the
placentae obtained from control (saline injected) and
treated (p(-MMC injected) mice. White blocks represent
control data and black-blocks represent data from
treated, mice. Included in the brackets are the number of
samples and the S.E.M. of the means are represented by






















Figure 75. A typical tracing of the contraction of an
isolated mouse uterus strip in response to the addition
of different concentractions of oxytocin added. The
arrows indicate the time of oxytocin addition and the




















Figure 76 Dose-response curves of uteri samples obtained
from day 11 after drug X-MMC administration. Double
reciprocal plots yield Emnax of 1.19±0.10 in the control
(closed circle, N=6) and 0.60+0.12 in the treated group
(open circle, N=12). t-test shows a significant
difference (p0.01). The LogED50 of the two curves are-
2.55+0.33 (·) and -2.09+0.20 (0) respectively and there
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Figure 77. Dose-response curves of uteri samples
obtained from day 13 after drug 0(-MMC administration.
Double reciprocal plots yield Emax of 1.21±0.13 in the
control (closed circle, N=12) and 0.57±0.04 in the
treated group (open circle, N=8). t-test shows a
significant difference (p0.001). The LogED50 of the two
curves.are -2.51±0.28 ( ) and -2.02+0.18 ( ) respectively
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Figure 78. Dose-response curves of uteri samples
obtained from day 15 after drug a-MMC administration.
Double reciprocal plots yield Emax of 1.06+0.19 in the
control (closed circle, N=7) and 0.67±0.19 in the treated
group (open circle, N=6). t-test shows. a significant
difference (p0.05). The LogED50 of the two curves are-
2.31+0.37( ) and -2.85+0.31 ( ) respectively and there
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Figure 79. Dose-response curves of uteri samples
obtained from day 17 after drug a-MMC administration.
Double reciprocal plots yield Emax of 1.22+0.16 in the
control (closed circle, N=15) and 0.77±0.13 in the
treated group (open circle, N=12). t-test shows a.
significant difference (p0.05). The LogED50 of the two
curves are -2.52±0.28 ( ) and -2.03±0.18 ( ) respectively
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Figure 80. Dose-response curves of uteri samples
obtained from day 19 after drug a-MMC administration.
Double reciprocal plots yield Emax of 1.11+0.16 in the
control (closed circle, N=6) and 0.77+0.11 in the treated
group (open circle, N=6). t-test shows no significant
difference (p0.05). The LogED50 of the two curves are-
2.83±0.31 ( ) and -2.57±0.21 ( ) respectively and there
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Figure 81. Dose-response curves of uteri samples
obtained from day 21 after drug a-MMC administration.
Double reciprocal plots yield Emax of 1.18+0.08 in the
control (closed circle, N=9) and Q.80±0.05 in the treated
group (open circle, N=9). t-test shows.. a significant
difference (p0.05). The LogED50 of the two curves are-
2.40+0.42 (·) and -1.96±0.46 (0) respectively and there
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Figure 82. Dose-response curves of uteri samples
obtained from day '23 after drug x-MMC administration.
Double reciprocal plots yield Emax of 1.17±0.26 in the
control (closed circle, N=8) and 0.98±0.08 in the treated
group (open circle, N=8). t-test shows- no significant
difference (p0.05). The LogED50 of the two curves are-
2.18+0.21( ) and -2.20±0.25 ( ) respectively and there
























Figure 33. Dose-response curves of uteri samples
obtained from day 25 of ter drug o-'L•9MC administration.
Double reciprocal plots yield Emriax of 0.99+.11 in the
control (closed circle, N=8) and 1.11+0.18 in the treated
group (open circle, N=9). t-test shows no significant
difference (p0.05). The LogED50 of the two curves are-
2.00+0.25(•) and -2.47+0.41 (0) respectively and there
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23.8+1.7 p0.0522.9+1.01.Day of second mating
after saline or a-MMC
injection
17.8+0.818.4+0.32.Day of second p0.05
parturition
8.0+1.83.Number of fetuses of 6.8+0.9 p0.05
second-pregnancy
TABLE 2. Comparison of three parameters of second
pregnancy between control (saline injected) and treated (a
-MMC injected) mice. No significanct difference is found
any of the parameters.
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APPENDIX
1. Tissue Preparation Procedure tor Light microscopy
TimeReagents andProcedure
Conditions












1 hourparaffin at 58'CInfiltration
1 hourDaraf f in at 58°C
30 minparattin at 56 C
(vacuum aspiration)
paraffin (cool down and trim)Embedding
Sectioning (at 5 micron thickness), then adhered on












5 min.running tap water
2 min.Mayer's HematoxylinStaining
Differentiation 5 min.running tap water
1 min.EosinCounter-staining








(1: 1) dried on warm
plate
The slides can be examined with the Nikon Optiphot light
microscope.
Photographs can also be taken with the Nikon FX-35A camera




several daysFixation 2% glutaraldehyde
in buffer at 4°C
overnight0.2M sodium cacodylateBuffer wash
buffer with sucrose
pH 7.3 at 4°C
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2 hours1% osmium tetroxidePost-fixation
in buffer at 4°C
0.2M sodium cacodylate buffer withBuffer wash
sucrose pH 7.3 at 4°C
5 min.Partial dehydration 30% ethanol at 4°C
5 min.50% ethanol at 4°C
70% ethanol at 4°C 5 min.
placentae quench in liquid nitrogenFreeze-fracturing
fracture with a blade
Complete 5 min.70% ethanol at 4°C
dehydration
5 min.85% ethanol at 4°C
15 min.95% ethanol at 4°C
15 min.100% ethanol at
room temperature





liquid carbon dioxideCritical Point
Drying
on metal stubs with conducting silverMounting
paint, allow to dry for at least 1 hour
in a decisscator
with palladium in a rotary high-vacuumCoating
evaporator
The specimens can be examined and photographed with JOEL-















0.1ghematein (grind in 5ml alcohol)
100m15% aqueous potassium alum





8. 0.2M'sodium cacodylate buffer with sucrose pH 7.3
48.2gsodium cacodylate
73.Ogsucrose(0.25M)
distille water added to make up 1 liter




340 ml0.2M sodium cacodvlate buffer with sucrose
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10. 1% osmium tetroxide
0.5gosmium tetroxide
(1 ampoule)
50ml0.2M sodium cacodylate buffer with sucrose
11. RSL Quan- Preg
Reagents include:
A.Diluent buffer: 0.005% rabbit gamma globulins in 0.01M
phosphosaline buffer pH 7.5 containing
EDTA and BSA
b.Anti-hCG-(3: Purified hCG- (3 -subunit was used as the
antigen to generate antiserum in rabbits.
c.hCG standards: Concentrations of 0.5, 1.0, 2.5, 5.0,
10.0, 25.0 ng/ml diluted in diluent
buffer
d.Second antibody-PEG: A mixture of goat anti-rabbit
(Precipitant solution) gamma globulins and PEG-6000 is
contained in a 0.01M
phosphocaline buffer, pH 7.5
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e. hCG- I: Labelled iodinated form of. hCG
12. Modified Van Dyke-Hastings solution
a. Stock solution I: sodium chloride 120.67g
46.62gsodium hydrogen carbonate
8.27gpotassium chloride
distilled water add to make
18 litres
b. Stock solution II:
i) disodium hydrogen orthophosphate(anhydrous) 22.7142
distilled water add to make
1 litre
ii) sodium dihydrogen,orthophosphate 5.520g
(NaH 2POk4- H20)
distilled water add to make
1 litre
Titrate the two i) and ii) solutions to pH 7.4
c. Stock solution III: calcium chloride 73.515g/l
(CaCl2•2H20)
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d. Stock solution IV: magnesium chloride 101.665g/l
(MgCl2• (6H2O)
To prepare 1 liter of the working solution, mix 988 ml of
Stock solution I with 10ml of Stock solution 1I
(phosphate buffer), 1 ml of Stock solution III (calcium
chloride) and 1 ml of Stock solution IV (magnesium
chloride). Then add 0.5g glucose. When dissolved, the
solution is ready to gas with 5% carbon dioxide in oxygen
to adjust a pH of 7.4


